col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


509 Results       Page 1

 [1] 
Elsevier: EClinicalMedicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―17 Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study Meijun Meng, Rui Wei, Yanjun Wu, Ruijie Zeng, Dongling Luo, Yuying Ma, et al. (+7)
2 [GO] 2024―Feb―09 Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials Ilias I. Siempos, Andre C. Kalil, Drifa Belhadi, Viviane Cordeiro Veiga, Alexandre Biasi Cavalcanti, Westyn Branch-Elliman, et al. (+1262)
3 [GO] 2024―Feb―09 Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world study Shuxia Wang, Jin Sun, Xin Zhang, Man Li, Bangguo Qin, Miao Liu, et al. (+41)
4 [GO] 2024―Jan―11 The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study Sarah M. Bartsch, Kelly J. O'Shea, Danielle C. John, Ulrich Strych, Maria Elena Bottazzi, Marie F. Martinez, et al. (+8)
5 [GO] 2024―Jan―08 Disproportionate infection, hospitalisation and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework Patricia Irizar, Daniel Pan, Harry Taylor, Christopher A. Martin, Srinivasa Vittal Katikireddi, Niluka Wijekoon Kannangarage, et al. (+8)
6 [GO] 2024―Jan―05 Estimating the return on investment of selected infection prevention and control interventions in healthcare settings for preparing against novel respiratory viruses: modelling the experience from SARS-CoV-2 among health workers Ece Özçelik, Aliénor Lerouge, Michele Cecchini, Alessandro Cassini, Benedetta Allegranzi
7 [GO] 2024―Jan―03 Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial Suzana Margareth Lobo, Gaétan Plantefève, Girish Nair, Adilson Joaquim Cavalcante, Nara Franzin de Moraes, Estevao Nunes, et al. (+45)
8 [GO] 2024―Jan―02 The rise of home death in the COVID-19 pandemic: a population-based study of death certificate data for adults from 32 countries, 2012-2021 Sílvia Lopes, Andrea Bruno de Sousa, Mayra Delalibera, Elizabeth Namukwaya, Joachim Cohen, Barbara Gomes
9 [GO] 2023―Dec―15 Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial Yangqing Zhan, Zhengshi Lin, Jingyi Liang, Ruilin Sun, Yueping Li, Bingliang Lin, et al. (+33)
10 [GO] 2023―Dec―13 Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective cohort study Hongfei Mi, Qi Chen, Hongyan Lin, Tingjuan He, Ruixin Zhang, Shuhao Ren, et al. (+6)
11 [GO] 2023―Dec―13 Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos) Yi Fang, Jing-Xin Li, Davone Duangdany, Yang Li, Xi-Lin Guo, Chanthala Phamisith, et al. (+16)
12 [GO] 2023―Dec―08 COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis Isabella Michelon, Maysa Vilbert, Isabella Silveira Pinheiro, Isabela Lino Costa, Cecilia Fernandes Lorea, Mathias Castonguay, et al. (+2)
13 [GO] 2023―Dec―06 Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial Maya C. Andre, Sanchez Carlos, Bressieux-Degueldre Sabrina, Perez Marie-Helene, Wütz Daniela, Blanchard-Rohner Geraldine, et al. (+89)
14 [GO] 2023―Dec―05 Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study Raffaele Izzo, Daniela Pacella, Valentina Trimarco, Maria Virginia Manzi, Angela Lombardi, Roberto Piccinocchi, et al. (+7)
15 [GO] 2023―Nov―24 Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study Xiaomin Zhong, Diane Ashiru-Oredope, Alexander Pate, Glen P. Martin, Anita Sharma, Paul Dark, et al. (+58)
16 [GO] 2023―Nov―03 Safety and effectiveness of COVID-19 vaccines in patients with IgA nephropathy: a retrospective cohort study from the TriNetX global collaborative networks Cheng-Hsu Chen, Ming-Ju Wu, Shang-Feng Tsai
17 [GO] 2023―Oct―09 Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey Bradley J. Langford, Valerie Leung, Jennifer Lo, Elie A. Akl, Robby Nieuwlaat, Tamara Lotfi, et al. (+4)
18 [GO] 2023―Oct―06 Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study Giulia Vivaldi, Paul E. Pfeffer, Mohammad Talaei, Tariro Jayson Basera, Seif O. Shaheen, Adrian R. Martineau
19 [GO] 2023―Oct―06 Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial Prasanna Jagannathan, Kara W. Chew, Mark J. Giganti, Michael D. Hughes, Carlee Moser, Mark J. Main, et al. (+110)
20 [GO] 2023―Oct―05 Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study Zhigang Liu, James L. Alexander, Kaixing Le, Xin Zhou, Hajir Ibraheim, Sulak Anandabaskaran, et al. (+66)
21 [GO] 2023―Oct―04 Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial Gernot Rohde, Stephan Stenglein, Hans Prozesky, Ganesh Manudhane, Oana Sandulescu, Martin Bauer, et al. (+6)
22 [GO] 2023―Sep―21 Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial Xiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, Jingjing Chen, Qianhui Wu, Yan Zheng, et al. (+15)
23 [GO] 2023―Sep―20 Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study Eric Yuk Fai Wan, Vincent Ka Chun Yan, Zoey Cho Ting Wong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+5)
24 [GO] 2023―Sep―14 Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium Francesca Sperotto, Alba Gutiérrez-Sacristán, Simran Makwana, Xiudi Li, Valerie N. Rofeberg, Tianxi Cai, et al. (+289)
25 [GO] 2023―Sep―12 Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, et al. (+122)
26 [GO] 2023―Sep―08 Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial Suad Hannawi, Lixin Yan, Linda Saifeldin, Alaa Abuquta, Ahmad Alamadi, Sally A. Mahmoud, et al. (+6)
27 [GO] 2023―Sep―07 Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial Joon Young Song, Won Suk Choi, Jung Yeon Heo, Eun Jin Kim, Jin Soo Lee, Dong Sik Jung, et al. (+55)
28 [GO] 2023―Aug―31 Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial Bei Wang, Hai-jun Li, Mi-mi Cai, Zhao-xin Lin, Xia-fei Ou, Shu-hua Wu, et al. (+7)
29 [GO] 2023―Aug―18 Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study) Zurina Cinza-Estévez, Sonia Resik-Aguirre, Nelvis L. Figueroa-Baile, Rachel Oquendo-Martínez, Ivan Campa-Legrá, Alina Tejeda-Fuentes, et al. (+114)
30 [GO] 2023―Aug―16 Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study Kuan Peng, Xue Li, Deliang Yang, Shirley C.W. Chan, Jiayi Zhou, Eric Y.F. Wan, et al. (+7)
31 [GO] 2023―Jul―29 Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study Guy de Bruyn, Joyce Wang, Annie Purvis, Martin Sanchez Ruiz, Haritha Adhikarla, Saad Alvi, et al. (+152)
32 [GO] 2023―Jul―27 Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial Shaahin Shahbazi, Zahra Vahdat Shariatpanahi, Erfan Shahbazi
33 [GO] 2023―Jul―26 Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981] Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng, Xiang Chen, Guangtong Deng
34 [GO] 2023―Jul―26 Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study Hussam Ghoti, Hala Zreid, Israa Ghoti, Arno R. Bourgonje, Arjan Diepstra, Harry van Goor, et al. (+4)
35 [GO] 2023―Jul―21 The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study Nathan J. Cheetham, Rose Penfold, Valentina Giunchiglia, Vicky Bowyer, Carole H. Sudre, Liane S. Canas, et al. (+18)
36 [GO] 2023―Jul―20 Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening Joachim Worthington, Francine van Wifferen, Zhuolu Sun, Lucie de Jonge, Jie-Bin Lew, Marjolein J.E. Greuter, et al. (+6)
37 [GO] 2023―Jul―20 Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study Suelen H. Qassim, Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, Patrick Tang, Hadi M. Yassine, et al. (+18)
38 [GO] 2023―Jul―20 Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study Sophie C. Frölke, Pim Bouwmans, A. Lianne Messchendorp, Johanna P.M. Vervoort, Alferso C. Abrahams, Aiko P.J. de Vries, et al. (+47)
39 [GO] 2023―Jul―20 Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial José A. Castro-Rodriguez, Eleanor N. Fish, Samuel T. Montgomery, Tobias R. Kollmann, Carolina Iturriaga, Casey Shannon, et al. (+16)
40 [GO] 2023―Jul―11 Are clinical outcomes from COVID-19 improving in ethnic minority groups? Daniel Pan, Shirley Sze, Patricia Irizar, Nisha George, Aasiya Chaka, Zainab Lal, et al. (+8)
41 [GO] 2023―Jul―06 Why has the epidemiology of RSV changed during the COVID-19 pandemic? Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, Pascal Michel Lavoie
42 [GO] 2023―Jul―05 Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection (OpenSAFELY): a matched case-control study Ya-Ting Yang, David Wong, Darren M. Ashcroft, Jon Massey, Brian MacKenna, Louis Fisher, et al. (+8)
43 [GO] 2023―Jun―29 Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform Ruth E. Costello, John Tazare, Dominik Piehlmaier, Emily Herrett, Edward P.K. Parker, Bang Zheng, et al. (+263)
44 [GO] 2023―Jun―22 Comparing SARS-CoV-2 testing positivity rates and COVID-19 impact among different isolation strategies: a rapid systematic review and a modelling study Ya Gao, Yunli Zhao, Xi Zhang, Jinhui Tian, Gordon Guyatt, Qiukui Hao
45 [GO] 2023―Jun―16 Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, et al. (+65)
46 [GO] 2023―Jun―09 Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, Ombeline Empis de Vendin, Guillaume de Ciancio, Jean-Benoît Arlet, et al. (+293)
47 [GO] 2023―Jun―06 Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study Markus Hovd, Anders Åsberg, Ludvig A. Munthe, Kristian Heldal, Anna V. Reisæter, John T. Vaage, et al. (+2)
48 [GO] 2023―May―31 Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial Bruno François, Simon Lambden, Jean-Jacques Garaud, Marc Derive, Jean-Marie Grouin, Pierre Asfar, et al. (+16)
49 [GO] 2023―May―18 Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial Álvaro Avezum, Haliton Alves Oliveira Junior, Precil Diego M.M. Neves, Lucas Bassolli O. Alves, Alexandre B. Cavalcanti, Regis G. Rosa, et al. (+24)
50 [GO] 2023―May―11 Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, et al. (+9)
51 [GO] 2023―May―05 Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng, Xiang Chen, Guangtong Deng
52 [GO] 2023―Apr―27 SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, et al. (+22)
53 [GO] 2023―Apr―13 Corrigendum to “Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks” Weijie Wang, Chi-Yen Wang, Shiow-Ing Wang, James Cheng-Chung Wei
54 [GO] 2023―Apr―12 Vaccines and therapeutics for immunocompromised patients with COVID-19 Shmuel Shoham, Carolina Batista, Yanis Ben Amor, Onder Ergonul, Mazen Hassanain, Peter Hotez, et al. (+11)
55 [GO] 2023―Apr―06 Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, et al. (+58)
56 [GO] 2023―Apr―06 Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry Jon Salmanton-García, Francesco Marchesi, Maria Gomes da Silva, Francesca Farina, Julio Dávila-Valls, Yavuz M. Bilgin, et al. (+110)
57 [GO] 2023―Apr―04 Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis Christopher A. Martin, Joshua Nazareth, Amar Jarkhi, Daniel Pan, Mrinal Das, Nicola Logan, et al. (+27)
58 [GO] 2023―Mar―11 Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study Hamish J.C. McAuley, Rachael A. Evans, Charlotte E. Bolton, Christopher E. Brightling, James D. Chalmers, Annemarie B. Docherty, et al. (+1047)
59 [GO] 2023―Mar―10 Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) Ilaria Mastrorosa, Roberta Gagliardini, Francesco Vladimiro Segala, Annalisa Mondi, Patrizia Lorenzini, Carlotta Cerva, et al. (+88)
60 [GO] 2023―Mar―10 Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial Andrea Alemany, Pere Millat-Martinez, Marc Corbacho-Monné, Clara Suñer, Cristina Galvan-Casas, Caty Carrera, et al. (+241)
61 [GO] 2023―Mar―06 Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants Patricia Irizar, Daniel Pan, Dharmi Kapadia, Laia Bécares, Shirley Sze, Harry Taylor, et al. (+7)
62 [GO] 2023―Mar―02 Aberrant olfactory network functional connectivity in people with olfactory dysfunction following COVID-19 infection: an exploratory, observational study Jed Wingrove, Janine Makaronidis, Ferran Prados, Baris Kanber, Marios C. Yiannakas, Cormac Magee, et al. (+8)
63 [GO] 2023―Mar―01 Association of preoperative COVID-19 and postoperative respiratory morbidity during the Omicron epidemic wave: the DROMIS-22 multicentre prospective observational cohort study Marc Garnier, Jean-Michel Constantin, Raphaël Cinotti, Chafia Daoui, Dimitri Margetis, Grégory Destruhaut, et al. (+115)
64 [GO] 2023―Feb―21 Born into an isolating world: family-centred care for babies born to mothers with COVID-19 G. Dowse, E.J. Perkins, H.M. Stein, G. Chidini, O. Danhaive, Y.N. Elsayed, et al. (+76)
65 [GO] 2023―Feb―16 Impact of the COVID-19 pandemic on incidence of tics in children and young people: a population-based cohort study Ruth H. Jack, Rebecca M. Joseph, Carol A.C. Coupland, Charlotte L. Hall, Chris Hollis
66 [GO] 2023―Feb―16 Breaking the cycle of neglect: building on momentum from COVID-19 to drive access to diagnostic testing Emma Hannay, Madhukar Pai
67 [GO] 2023―Feb―16 SARS-CoV-2-neutralising antibody BGB-DXP593 in mild-to-moderate COVID-19: a multicentre, randomised, double-blind, phase 2 trial Ramses Vega, Martti Antila, Carlos Perez, Mohamed Mookadam, Fangjie Xie, Wei Zhang, et al. (+3)
68 [GO] 2023―Feb―06 Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022 Arindam Nandi, Simone Pecetta, David E. Bloom
69 [GO] 2023―Feb―03 Access to information on gender-based violence prevention during COVID-19 lockdown in Uganda: a cross-sectional study Paul Bukuluki, Peter Kisaakye, Symon Peter Wandiembe, Grace Bulenzi-Gulere, Beatrice Mulindwa, Dan Bazira, et al. (+5)
70 [GO] 2023―Jan―20 COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases Ponlagrit Kumwichar, Virasakdi Chongsuvivatwong
71 [GO] 2023―Jan―13 COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 Alex J. Szubert, Katrina M. Pollock, Hannah M. Cheeseman, Jasmini Alagaratnam, Henry Bern, Olivia Bird, et al. (+24)
72 [GO] 2023―Jan―10 Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study Renin Chang, Thomas Yen-Ting Chen, Shiow-Ing Wang, Yao-Min Hung, Hui-Yuan Chen, Cheng-Chung James Wei
73 [GO] 2022―Dec―30 Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi Upendo L. Mseka, Jonathan Mandolo, Kenneth Nyoni, Oscar Divala, Dzinkambani Kambalame, Daniel Mapemba, et al. (+25)
74 [GO] 2022―Dec―28 SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, Hamid Parsa, Sanaz Mahjour, Fatemeh Safarpour, et al. (+9)
75 [GO] 2022―Dec―26 Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, et al. (+42)
76 [GO] 2022―Nov―25 Reliability and validity of the post COVID-19 condition stigma questionnaire: A prospective cohort study Ronald W. Damant, Liam Rourke, Ying Cui, Grace Y. Lam, Maeve P. Smith, Desi P. Fuhr, et al. (+7)
77 [GO] 2022―Nov―21 Spousal support and work performance during the COVID-19 pandemic among elected women representatives in rural Bihar, India: A cross-sectional, mixed-methods study Anamika Priyadarshini, Nabamallika Dehingia, Madhu Joshi, Devaki Singh, Shiney Chakraborty, Anita Raj
78 [GO] 2022―Nov―17 Factors affecting delayed and non-receipt of healthcare during the COVID-19 pandemic for women in rural Maharashtra, India: Evidence from a cross-sectional study Arnab K. Dey, Nandita Bhan, Namratha Rao, Mohan Ghule, Sangeeta Chatterji, Anita Raj
79 [GO] 2022―Nov―17 Gender and the COVID-19 pandemic: Multinational research indicate that we must support and compensate LMIC women's leadership in crises Anita Raj
80 [GO] 2022―Nov―12 Automated vs. manual case investigation and contact tracing for pandemic surveillance: Evidence from a stepped wedge cluster randomized trial Cameron Raymond, Derek Ouyang, Alexis D'Agostino, Sarah L. Rudman, Daniel E. Ho
81 [GO] 2022―Nov―07 Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study Byorn W.L. Tan, Bryce W.Q. Tan, Amelia L.M. Tan, Emily R. Schriver, Alba Gutiérrez-Sacristán, Priyam Das, et al. (+298)
82 [GO] 2022―Nov―01 Suicide spectrum among young people during the COVID-19 pandemic: A systematic review and meta-analysis Michela Bersia, Emanuele Koumantakis, Paola Berchialla, Lorena Charrier, Andrea Ricotti, Piercesare Grimaldi, et al. (+2)
83 [GO] 2022―Oct―20 Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial James H. McMahon, Jillian S.Y. Lau, Anna Coldham, Janine Roney, Michelle Hagenauer, Sally Price, et al. (+27)
84 [GO] 2022―Oct―20 Response to: ‘Concerns about ‘Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks’ by Renin Chang et al Weijie Wang, Shiow-Ing Wang, James Cheng-Chung Wei
85 [GO] 2022―Oct―20 Concerns about Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks Renin Chang, Cheuk-Kwan Sun, Yao-Min Hung
86 [GO] 2022―Sep―28 Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study Hui Zhang, Xia Li, Lixue Huang, Xiaoyin Gu, Yimin Wang, Min Liu, et al. (+6)
87 [GO] 2022―Sep―28 Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial Yuemiao Zhang, Xupu Ma, Guanghong Yan, Ying Wu, Yanli Chen, Zumi Zhou, et al. (+13)
88 [GO] 2022―Sep―23 Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States Fan Lv, Xu Gao, Amy Huaishiuan Huang, Jian Zu, Xinyuan He, Xiaodan Sun, et al. (+8)
89 [GO] 2022―Sep―21 Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial Pierre Kalfon, Jean-François Payen, Alexandra Rousseau, Benjamin Chousterman, Marine Cachanado, Annick Tibi, et al. (+8)
90 [GO] 2022―Sep―17 Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial Matthias Hepprich, Jonathan M. Mudry, Claudia Gregoriano, Francois R. Jornayvaz, Sebastian Carballo, Anne Wojtusciszyn, et al. (+20)
91 [GO] 2022―Sep―17 Natural and hybrid immunity following four COVID-19 waves: A prospective cohort study of mothers in South Africa Heather J. Zar, Rae MacGinty, Lesley Workman, Maresa Botha, Marina Johnson, Adam Hunt, et al. (+5)
92 [GO] 2022―Sep―17 Fatigue and cognitive impairment after COVID-19: A prospective multicentre study Tim J. Hartung, Christian Neumann, Thomas Bahmer, Irina Chaplinskaya-Sobol, Matthias Endres, Johanna Geritz, et al. (+20)
93 [GO] 2022―Sep―14 COVID-19 and family violence: A rapid review of literature published up to 1 year after the pandemic declaration Nicole Letourneau, Mayara Alves Luis, Stefan Kurbatfinski, Hannah J. Ferrara, Carrie Pohl, Franciele Marabotti, K. Alix Hayden
94 [GO] 2022―Sep―13 Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.” Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, Anna Annunziata, Mariano Bernardo, Angela Lombardi, et al. (+3)
95 [GO] 2022―Sep―09 Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients Tina Thomson, Maria Prendecki, Sarah Gleeson, Paul Martin, Katrina Spensley, Rute Cardoso De Aguiar, et al. (+12)
96 [GO] 2022―Sep―06 Crowdsourcing interventions to promote uptake of COVID-19 booster vaccines Robert Böhm, Cornelia Betsch, Yana Litovsky, Philipp Sprengholz, Noel T. Brewer, Gretchen Chapman, et al. (+5)
97 [GO] 2022―Aug―27 Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review Kin Israel Notarte, Jesus Alfonso Catahay, Jacqueline Veronica Velasco, Adriel Pastrana, Abbygail Therese Ver, Flos Carmeli Pangilinan, et al. (+7)
98 [GO] 2022―Aug―18 A randomised, double-blind, placebo-controlled, multicentre clinical trial of AZD1656 in diabetic patients hospitalised with COVID-19: The ARCADIA Trial - implications for therapeutic immune modulation Jamie Chorlton, Zoe Hollowood, Carlene Dyer, Donna Lockhart, Pascal Boekman, Kieran McCafferty, et al. (+3)
99 [GO] 2022―Aug―11 Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks Weijie Wang, Chi-Yen Wang, Shiow-Ing Wang, James Cheng-Chung Wei
100 [GO] 2022―Aug―03 COVID-19 and the gendered impacts on adolescent wellbeing: Evidence from a cross-sectional study of locally adapted measures in Ethiopia, Jordan, and Palestine Erin Oakley, Shoroq Abuhamad, Jennifer Seager, Benjamin Avuwadah, Joan Hamory, Nicola Jones, et al. (+4)
101 [GO] 2022―Aug―03 COVID-19 burden, author affiliation and women's well-being: A bibliometric analysis of COVID-19 related publications including focus on low- and middle-income countries Lotus McDougal, Nabamallika Dehingia, Wendy Wei Cheung, Anvita Dixit, Anita Raj
102 [GO] 2022―Aug―03 Gender differences in work attendance among health care workers in Northern Nigeria during the COVID-19 pandemic Modupe Taiwo, Oluwatoyin Oyekenu, Ferdinard Ekeh, Arnab K. Dey, Anita Raj
103 [GO] 2022―Aug―02 Suicide numbers during the first 9-15 months of the COVID-19 pandemic compared with pre-existing trends: An interrupted time series analysis in 33 countries Jane Pirkis, David Gunnell, Sangsoo Shin, Marcos Del Pozo-Banos, Vikas Arya, Pablo Analuisa Aguilar, et al. (+90)
104 [GO] 2022―Jul―22 Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study Timothée Bruel, Laurie Pinaud, Laura Tondeur, Delphine Planas, Isabelle Staropoli, Françoise Porrot, et al. (+16)
105 [GO] 2022―Jul―22 Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, et al. (+24)
106 [GO] 2022―Jul―18 At home and at risk: The experiences of Irish adults living with obesity during the COVID-19 pandemic Emma Farrell, Eva Hollmann, Carel Le Roux, Joe Nadglowski, Deirdre McGillicuddy
107 [GO] 2022―Jul―15 Reply to: Ethnic minorities, social media, and attitudes towards COVID-19 vaccination Fidelia Cascini, Giovanna Failla, Andriy Melnyk
108 [GO] 2022―Jul―15 Ethnic minorities, social media, and attitudes towards COVID-19 vaccination Iliana Sarafian
109 [GO] 2022―Jul―11 Understanding chronic Covid-19 Thomas Milovac
110 [GO] 2022―Jul―10 Response to “Understanding chronic Covid-19 Adam Hampshire, David K. Menon
111 [GO] 2022―Jul―09 Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis Weiqi Yao, Haibo Dong, Ji Qi, Yu Zhang, Lei Shi
112 [GO] 2022―Jul―01 Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study Ana Ascaso-del-Rio, Javier García-Pérez, Mayte Pérez-Olmeda, Eunate Arana-Arri, Itziar Vergara, Carla Pérez-Ingidua, et al. (+14)
113 [GO] 2022―Jul―01 Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study Lucy Marsden, David M. Hughes, Rhiannon Corcoran, Christopher P. Cheyne, Matt Ashton, Iain Buchan, et al. (+2)
114 [GO] 2022―Jul―01 Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study Javier García-Pérez, María González-Pérez, María Castillo de la Osa, Alberto M. Borobia, Luis Castaño, María Jesús Bertrán, et al. (+24)
115 [GO] 2022―Jun―25 Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up Berik Khairullin, Kunsulu Zakarya, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Gulbanu Sarsenbayeva, et al. (+17)
116 [GO] 2022―Jun―25 Strengthening health systems in crisis due to COVID-19 requires ending violence against female healthcare workers Arnab K. Dey, Katherine Hay, Anita Raj
117 [GO] 2022―Jun―25 Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study Celine Sze Ling Chui, Min Fan, Eric Yuk Fai Wan, Miriam Tim Yin Leung, Edmund Cheung, Vincent Ka Chun Yan, et al. (+25)
118 [GO] 2022―Jun―25 COVID-19 vaccine hesitancy amongst healthcare workers: An assessment of its magnitude and determinants during the initial phase of national vaccine deployment in Nigeria Terna Nomhwange, Oghenebrume Wariri, Esin Nkereuwem, Scholastica Olanrewaju, Ngozi Nwosu, Usman Adamu, et al. (+6)
119 [GO] 2022―Jun―13 Area-level socioeconomic deprivation, non-national residency, and Covid-19 incidence: A longitudinal spatiotemporal analysis in Germany Sven Rohleder, Dr. Diogo Costa, Prof Kayvan Bozorgmehr
120 [GO] 2022―Jun―09 A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study Ziyue Wang, Adam Cryar, Oliver Lemke, Pinkus Tober-Lau, Daniela Ludwig, Elisa Theresa Helbig, et al. (+14)
121 [GO] 2022―Jun―04 Gendered time use during COVID-19 among adolescents and young adults in Nairobi, Kenya Anaise Williams, Shannon N. Wood, H.Colleen Stuart, Grace Wamue-Ngare, Mary Thiongo, Peter Gichangi, et al. (+2)
122 [GO] 2022―Jun―03 Baricitinib as the treatment of choice for hospitalised individuals with COVID-19 Peter J. Richardson, Justin Stebbing
123 [GO] 2022―Jun―03 Product-access challenges to menstrual health throughout the COVID-19 pandemic among a cohort of adolescent girls and young women in Nairobi, Kenya Shannon N. Wood, Rachel Milkovich, Mary Thiongo, Meagan E. Byrne, Bianca Devoto, Grace Wamue-Ngare, et al. (+2)
124 [GO] 2022―Jun―03 Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trial Jiro Terada, Retsu Fujita, Takuya Kawahara, Yasutaka Hirasawa, Taku Kinoshita, Yuichiro Takeshita, et al. (+5)
125 [GO] 2022―Jun―03 Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials Vijairam Selvaraj, Arkadiy Finn, Amos Lal, Mohammad Saud Khan, Kwame Dapaah-Afriyie, Gerardo P. Carino
126 [GO] 2022―May―29 On race and ethnicity during a global pandemic: An ‘imperfect mosaic’ of maternal and child health services in ethnically-diverse South London, United Kingdom Sergio A. Silverio, Kaat De Backer, Tisha Dasgupta, Ofelia Torres, Abigail Easter, Nina Khazaezadeh, et al. (+4)
127 [GO] 2022―May―27 Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients: A systematic review and meta-analysis Haopeng Zhi, Xiaolong Ji, Zifan Zhao, Hanwen Liang, Shuxin Zhong, Yiting Luo, et al. (+9)
128 [GO] 2022―May―27 Clinical presentation and short-term outcomes of multisystemic inflammatory syndrome in children in Lagos, Nigeria during the COVID-19 pandemic: A case series Ogochukwu Sokunbi, Yeside Akinbolagbe, Patricia Akintan, Gabriel Oyeleke, Olusola Kusimo, Uchenna Owowo, et al. (+13)
129 [GO] 2022―May―21 Changes and correlates of screen time in adults and children during the COVID-19 pandemic: A systematic review and meta-analysis Mike Trott, Robin Driscoll, Enrico Irlado, Shahina Pardhan
130 [GO] 2022―May―20 Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people Syed Ahmar Shah, Sinead Brophy, John Kennedy, Louis Fisher, Alex Walker, Brian Mackenna, et al. (+12)
131 [GO] 2022―May―20 Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study Vincent Auvigne, Sophie Vaux, Yann Le Strat, Justine Schaeffer, Lucie Fournier, Cynthia Tamandjou, et al. (+4)
132 [GO] 2022―May―20 Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients Jose Rafael Teran-Tinedo, Jesus Gonzalez-Rubio, Alberto Najera, Andrea Castany-Faro, Maria de las Nieves Contreras, Isabel Maria Garcia, et al. (+8)
133 [GO] 2022―May―20 Social media and attitudes towards a COVID-19 vaccination: A systematic review of the literature Fidelia Cascini, Ana Pantovic, Yazan A. Al-Ajlouni, Giovanna Failla, Valeria Puleo, Andriy Melnyk, et al. (+2)
134 [GO] 2022―May―14 Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 Dannebaum Richard, Suwalski Phillip, Asgharian Hosseinali, Du Zhipei Gracie, Lin Hai, Weiner January, et al. (+26)
135 [GO] 2022―May―12 A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19 Emanuele Nicastri, Franco Marinangeli, Emanuele Pivetta, Elena Torri, Francesco Reggiani, Giuseppe Fiorentino, et al. (+11)
136 [GO] 2022―May―12 Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial Caryn M. Upton, Rob C. van Wijk, Laurynas Mockeliunas, Ulrika S.H. Simonsson, Kirsten McHarry, Gerben van den Hoogen, et al. (+8)
137 [GO] 2022―May―12 The impact of post-hospital remote monitoring of COVID-19 patients using pulse oximetry: A national observational study using hospital activity data Theo Georghiou, Chris Sherlaw-Johnson, Efthalia Massou, Stephen Morris, Nadia E. Crellin, Lauren Herlitz, et al. (+5)
138 [GO] 2022―May―07 Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study Marc Chadeau-Hyam, Oliver Eales, Barbara Bodinier, Haowei Wang, David Haw, Matthew Whitaker, et al. (+14)
139 [GO] 2022―Apr―28 Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort Adam Hampshire, Doris A. Chatfield, Anne Manktelow MPhil, Amy Jolly, William Trender, Peter J. Hellyer, et al. (+14)
140 [GO] 2022―Apr―21 Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) Ivan O. Rosas, Norbert Bräu, Michael Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, et al. (+31)
141 [GO] 2022―Apr―18 Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands Hannah G. Juncker, Sien J. Mulleners, Eliza J.M. Ruhé, Esmée R.M. Coenen, Sjors Bakker, Maritt van Doesburg, et al. (+10)
142 [GO] 2022―Apr―15 SARS-COV2 placentitis and pregnancy outcome: A multicentre experience during the Alpha and early Delta waves of coronavirus pandemic in England Sophie Stenton, Jo McPartland, Rajeev Shukla, Kerry Turner, Tamas Marton, Beata Hargitai, et al. (+14)
143 [GO] 2022―Apr―12 Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis Peter Sarich, Citadel J Cabasag, Erica Liebermann, Pavla Vaneckova, Chelsea Carle, Suzanne Hughes, et al. (+10)
144 [GO] 2022―Apr―10 Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study) Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, Yenima Martín-Bauta, Zadis Navarro-Rodríguez, Marjoris Piñera-Martínez, Joel Quintana-Guerra, et al. (+24)
145 [GO] 2022―Apr―07 Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis Qi Zhou, Siya Zhao, Lidan Gan, Zhili Wang, Shuai Peng, Qinyuan Li, et al. (+9)
146 [GO] 2022―Mar―28 Neighbourhood socio-economic vulnerability and access to COVID-19 healthcare during the first two waves of the pandemic in Geneva, Switzerland: A gender perspective Denis Mongin, Stéphane Cullati, Michelle Kelly-Irving, Maevane Rosselet, Simon Regard, Delphine S. Courvoisier
147 [GO] 2022―Mar―25 Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy Vladimir A. Gushchin, Elena V. Tsyganova, Darya A. Ogarkova, Ruslan R. Adgamov, Dmitry V. Shcheblyakov, Nataliia V. Glukhoedova, et al. (+6)
148 [GO] 2022―Mar―25 Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group Olivier Hermine, Xavier Mariette, Raphael Porcher, Felix Djossou, Yann Nguyen, Jean-Benoît Arlet, et al. (+54)
149 [GO] 2022―Mar―25 Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study Vivek B. Kute, Deepak S. Ray, Feroz Aziz, Suraj M. Godara, Umapati Hegde, Anil KumarBT, et al. (+32)
150 [GO] 2022―Mar―15 Healthcare workers’ views on mandatory SARS-CoV-2 vaccination in the UK: A cross-sectional, mixed-methods analysis from the UK-REACH study Katherine Woolf, Mayuri Gogoi, Christopher A. Martin, Padmasayee Papineni, Susie Lagrata, Laura B. Nellums, et al. (+16)
151 [GO] 2022―Mar―13 Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic Brea Willey, Kayden Mimmack, Geoffroy Gagliardi, Michelle L. Dossett, Sharon Wang, Onyinye J Udeogu, et al. (+11)
152 [GO] 2022―Mar―12 Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum Amit Kaura, Adam Trickey, Anoop S V Shah, Umberto Benedetto, Ben Glampson, Abdulrahim Mulla, et al. (+8)
153 [GO] 2022―Mar―08 Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, et al. (+41)
154 [GO] 2022―Mar―07 Racial/Ethnic Disparities in Healthcare Worker Experiences During the COVID-19 Pandemic: An Analysis of the HERO Registry Jay B. Lusk, Haolin Xu, Laine E. Thomas, Lauren W. Cohen, Adrian F. Hernandez, Christopher B. Forrest, et al. (+4)
155 [GO] 2022―Mar―07 Variation in global COVID-19 symptoms by geography and by chronic disease: A global survey using the COVID-19 Symptom Mapper Balasundaram Kadirvelu, Gabriel Burcea, Jennifer K. Quint, Ceire E. Costelloe, A. Aldo Faisal
156 [GO] 2022―Mar―07 Inactivated SARS-CoV-2 vaccine for people with HIV Dawit Wolday, Tobias F. Rinke de Wit
157 [GO] 2022―Mar―05 Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system George N. Ioannou, Emily R. Locke, Pamela K. Green, Kristin Berry
158 [GO] 2022―Mar―01 The impact of remote home monitoring of people with COVID-19 using pulse oximetry: A national population and observational study Chris Sherlaw-Johnson, Theo Georghiou, Steve Morris, Nadia E. Crellin, Ian Litchfield, Efthalia Massou, et al. (+5)
159 [GO] 2022―Feb―28 A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 Jean-François Rossignol, Matthew C. Bardin, Jessica Fulgencio, Dena Mogelnicki, Christian Bréchot
160 [GO] 2022―Feb―26 Improving Asian American health during the Syndemic of COVID-19 and racism Anne Saw, Stella S. Yi, Lan N. Ðoàn, Janice Y. Tsoh, Aggie J. Yellow Horse, Simona C. Kwon, et al. (+3)
161 [GO] 2022―Feb―26 Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England Shamez N. Ladhani, Georgina Ireland, Frances Baawuah, Joanne Beckmann, Ifeanyichukwu O. Okike, Shazaad Ahmad, et al. (+16)
162 [GO] 2022―Feb―19 Detection of SARS-CoV-2 infection by exhaled breath spectral analysis: Introducing a ready-to-use point-of-care mass screening method Izhar Ben Shlomo, Hilel Frankenthal, Arie Laor, Ayala Kobo Greenhut
163 [GO] 2022―Feb―18 Burden of Covid-19 restrictions: National, regional and global estimates Günther Fink, Fabrizio Tediosi, Stefan Felder
164 [GO] 2022―Feb―11 Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: A systematic review and individual patient meta-analysis Rachel Harwood, Helen Yan, Nishanthi Talawila Da Camara, Clare Smith, Joseph Ward, Catrin Tudur-Smith, et al. (+10)
165 [GO] 2022―Feb―07 A systematic review of de-escalation strategies for redeployed staff and repurposed facilities in COVID-19 intensive care units (ICUs) during the pandemic Sigrún Eyrúnardóttir Clark, Georgia Chisnall, Cecilia Vindrola-Padros
166 [GO] 2022―Jan―28 Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis Aditya K Khetan, Salim Yusuf, Patricio Lopez-Jaramillo, Andrzej Szuba, Andres Orlandini, Nafiza Mat-Nasir, et al. (+26)
167 [GO] 2022―Jan―14 Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert, Vincenzo Libri, Marta Boffito, David Owen, et al. (+24)
168 [GO] 2022―Jan―06 Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months Mu Chen, Jingwei Liu, Ping Peng, Wenhua Jian, Yi Gao, Liman Fang, et al. (+10)
169 [GO] 2021―Dec―24 Evaluation of protection by COVID-19 vaccines after deployment in low and lower-middle income countries John Clemens, Asma Binte Aziz, Birkneh Tilahun Tadesse, Sophie Kang, Florian Marks, Jerome Kim
170 [GO] 2021―Dec―20 Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial H.G. Gaitán-Duarte, C. Álvarez-Moreno, C.J. Rincón-Rodríguez, N. Yomayusa-González, J.A. Cortés, J.C. Villar, et al. (+11)
171 [GO] 2021―Dec―13 The silent and dangerous inequity around access to COVID-19 testing: A call to action Carolina Batista, Peter Hotez, Yanis Ben Amor, Jerome H Kim, David Kaslow, Bhavna Lall, et al. (+16)
172 [GO] 2021―Dec―05 Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms Carl Wahlgren, Anestis Divanoglou, Melanie Larsson, Emma Nilsson, Åse Östholm Balkhed, Katarina Niward, et al. (+3)
173 [GO] 2021―Dec―04 Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study Yanmeng Feng, Yifan Zhang, Zhangyufan He, Haojie Huang, Xiangxiang Tian, Gang Wang, et al. (+9)
174 [GO] 2021―Dec―02 Disentangling post-vaccination symptoms from early COVID-19 Liane S. Canas, Marc F. Österdahl, Jie Deng, Christina Hu, Somesh Selvachandran, Lorenzo Polidori, et al. (+14)
175 [GO] 2021―Nov―30 A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, et al. (+25)
176 [GO] 2021―Nov―29 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study Shepherd R. Singer, Frederick J. Angulo, David L. Swerdlow, John M. McLaughlin, Itay Hazan, Netanel Ginish, et al. (+13)
177 [GO] 2021―Nov―23 Usual Interstitial Pneumonia is the Most Common Finding in Surgical Lung Biopsies from Patients with Persistent Interstitial Lung Disease Following Infection with SARS-CoV-2 Kristine E. Konopka, William Perry, Tao Huang, Carol F. Farver, Jeffrey L. Myers
178 [GO] 2021―Nov―20 A method for the identification of COVID-19 biomarkers in human breath using Proton Transfer Reaction Time-of-Flight Mass Spectrometry Aikaterini Liangou, Antonios Tasoglou, Heinz J. Huber, Christopher Wistrom, Kevin Brody, Prahlad G Menon, et al. (+8)
179 [GO] 2021―Nov―14 Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] Vinicius Fontanesi Blum, Sérgio Cimerman, James R Hunter, Paulo Tierno, Acioly Lacerda, Alexandre Soeiro, et al. (+11)
180 [GO] 2021―Nov―14 MERS-CoV Confirmation among 6,873 suspected persons and relevant Epidemiologic and Clinical Features, Saudi Arabia - 2014 to 2019 Shahul H. Ebrahim, Andrew D. Maher, Udhayashankar Kanagasabai, Sarah H. Alfaraj, Nojom A. Alzahrani, Saleh A. Alqahtani, et al. (+2)
181 [GO] 2021―Nov―06 Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial Niklaus D Labhardt, Mikaela Smit, Ianis Petignat, Thomas Perneger, Annalisa Marinosci, Pilar Ustero, et al. (+20)
182 [GO] 2021―Nov―01 Temporal trends in primary care-recorded self-harm during and beyond the first year of the COVID-19 pandemic: Time series analysis of electronic healthcare records for 2.8 million patients in the Greater Manchester Care Record Sarah Steeg, Lana Bojanić, George Tilston, Richard Williams, David A. Jenkins, Matthew J. Carr, et al. (+5)
183 [GO] 2021―Oct―30 Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection Eric HY Lau, David SC Hui, Owen TY Tsang, Wai-Hung Chan, Mike YW Kwan, Susan S Chiu, et al. (+7)
184 [GO] 2021―Oct―27 Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial Sergey V Zhuravel, Oleg K Khmelnitskiy, Oleg O Burlaka, Alexey I Gritsan, Boris M Goloshchekin, Seieun Kim, Ka Young Hong
185 [GO] 2021―Oct―25 With No Data, There's No Equity: Addressing the Lack of Data on COVID-19 for Asian American Communities Stella S. Yi, Lan N. Ðoàn, Juliet K. Choi, Jennifer A. Wong, Rienna Russo, Matthew Chin, et al. (+6)
186 [GO] 2021―Oct―25 Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial Göran Tornling, Rohit Batta, Joanna C. Porter, Bryan Williams, Thomas Bengtsson, Kartikeya Parmar, et al. (+6)
187 [GO] 2021―Oct―25 Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe Arun Fryatt, Victoria Simms, Tsitsi Bandason, Nicol Redzo, Ioana D. Olaru, Chiratidzo E Ndhlovu, et al. (+10)
188 [GO] 2021―Oct―22 Corrigendum to: Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967] Andrea Crafa, Rossella Cannarella, Rosita A. Condorelli, Laura M. Mongioì, Federica Barbagallo, Antonio Aversa, et al. (+2)
189 [GO] 2021―Oct―20 Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis Qianling Shi, Zijun Wang, Jiao Liu, Xingmei Wang, Qi Zhou, Qinyuan Li, et al. (+4)
190 [GO] 2021―Oct―19 BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study Galia Rahav, Yaniv Lustig, Jacob Lavee, Hila Magen, Tammy Hod, Einat Shacham Shmueli, et al. (+10)
191 [GO] 2021―Sep―30 An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam Nguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, Vo Minh Quang, Nguyen Thi Han Ny, Dao Bach Khoa, et al. (+31)
192 [GO] 2021―Sep―28 Willingness of children and adolescents to have a COVID-19 vaccination: Results of a large whole schools survey in England Mina Fazel, Stephen Puntis, Simon R. White, Alice Townsend, Karen L. Mansfield, Russell Viner, et al. (+3)
193 [GO] 2021―Sep―24 Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients Sameh M. Hozayen, Diana Zychowski, Sydney Benson, Pamela L. Lutsey, Jasmin Haslbauer, Alexandar Tzankov, et al. (+5)
194 [GO] 2021―Sep―12 Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina Soledad González, Santiago Olszevicki, Martín Salazar, Ana Calabria, Lorena Regairaz, Lupe Marín, et al. (+9)
195 [GO] 2021―Sep―12 Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China Yaping Wang, Ruchong Chen, Fengyu Hu, Yun Lan, Zhaowei Yang, Chen Zhan, et al. (+23)
196 [GO] 2021―Sep―12 Letter to the Editor regarding Leber W, Lammel O, Siebenhofer A, Redlberger-Fritz M, Panovska-Griffiths J, Czypionka T. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) Jonathan J Deeks
197 [GO] 2021―Sep―09 The potential impact of vaccine passports on inclination to accept COVID-19 vaccinations in the United Kingdom: Evidence from a large cross-sectional survey and modeling study Alexandre de Figueiredo, Heidi J. Larson, Stephen D. Reicher
198 [GO] 2021―Sep―09 Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis Giuseppe Fiorentino, Antonietta Coppola, Raffaele Izzo, Anna Annunziata, Mariano Bernardo, Angela Lombardi, et al. (+3)
199 [GO] 2021―Sep―08 Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action Lin Liu, Shu-Yu Ni, Wei Yan, Qing-Dong Lu, Yi-Miao Zhao, Ying-Ying Xu, et al. (+22)
200 [GO] 2021―Sep―08 Conventional oxygen therapy versus CPAP as a ceiling of care in ward-based patients with COVID-19: a multi-centre cohort evaluation. P Bradley, J Wilson, R Taylor, J Nixon, J Redfern, P Whittemore, et al. (+25)
201 [GO] 2021―Sep―03 Racial and ethnic disparity in clinical outcomes among patients with confirmed COVID-19 infection in a large US electronic health record database Ami R. Buikema, Paul Buzinec, Misti L. Paudel, Katherine Andrade, Jonathan C. Johnson, Yvette M. Edmonds, et al. (+10)
202 [GO] 2021―Sep―02 Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01 January Weiner, Phillip Suwalski, Manuel Holtgrewe, Alexander Rakitko, Charlotte Thibeault, Melina Müller, et al. (+64)
203 [GO] 2021―Sep―02 Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review Fidelia Cascini, Ana Pantovic, Yazan Al-Ajlouni, Giovanna Failla, Walter Ricciardi
204 [GO] 2021―Aug―31 Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents Alon Geva, Manish M. Patel, Margaret M. Newhams, Cameron C. Young, Mary Beth F. Son, Michele Kong, et al. (+40)
205 [GO] 2021―Aug―30 Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19 Raymund R. Razonable, Colin Pawlowski, John C. O'Horo, Lori L. Arndt, Richard Arndt, Dennis M. Bierle, et al. (+12)
206 [GO] 2021―Aug―28 Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Florian B. Mayr
207 [GO] 2021―Aug―28 Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea George A. Alba, David R. Ziehr, Jennifer N. Rouvina, Lida P. Hariri, Rachel S. Knipe, Benjamin D. Medoff, et al. (+6)
208 [GO] 2021―Aug―28 Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa Marycelin Mandu Baba, Molalegne Bitew, Joseph Fokam, Eric Agola Lelo, Ahmed Ahidjo, Kominist Asmamaw, et al. (+25)
209 [GO] 2021―Aug―26 Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]” Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, Marina Travacio, Ricardo Valentini, Daniel F. Alonso, et al. (+17)
210 [GO] 2021―Aug―25 Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial Alexander Joachim, Felix Dewald, Isabelle Suárez, Michael Zemlin, Isabelle Lang, Regine Stutz, et al. (+22)
211 [GO] 2021―Aug―20 Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global city Stephanie Fraser, Ralitsa Baranowski, Davide Patrini, Jay Nandi, May Al-Sahaf, Jeremy Smelt, et al. (+32)
212 [GO] 2021―Aug―14 Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan Kunsulu Zakarya, Lespek Kutumbetov, Mukhit Orynbayev, Yergali Abduraimov, Kulyaisan Sultankulova, Markhabat Kassenov, et al. (+6)
213 [GO] 2021―Aug―13 COVID-19 and the effects on pulmonary function following infection: A retrospective analysis Kristyn L. Lewis, Scott A. Helgeson, Mehmet M. Tatari, Jorge M. Mallea, Hassan Z. Baig, Neal M. Patel
214 [GO] 2021―Aug―13 Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) A. Pérez-Martínez, M. Mora-Rillo, C. Ferreras, P. Guerra-García, B. Pascual-Miguel, C. Mestre-Durán, et al. (+17)
215 [GO] 2021―Aug―12 The importation and establishment of community transmission of SARS-CoV-2 during the first eight weeks of the South African COVID-19 epidemic Kerrigan M. McCarthy, Stefano Tempia, Tendesayi Kufa, Jackie Kleynhans, Nicole Wolter, Waasila Jassat, et al. (+17)
216 [GO] 2021―Aug―12 Type 1 diabetes onset in Lombardy region, Italy, during the COVID-19 pandemic: The double-wave occurrence Chiara Mameli, Andrea Scaramuzza, Maddalena Macedoni, Giuseppe Marano, Giulio Frontino, Ester Luconi, et al. (+19)
217 [GO] 2021―Aug―12 Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study Laura A. Benjamin, Ross W. Paterson, Rachel Moll, Charis Pericleous, Rachel Brown, Puja R. Mehta, et al. (+30)
218 [GO] 2021―Aug―10 Your health is in your hands? US CDC COVID-19 mask guidance reveals the moral foundations of public health Cecília Tomori, Aziza Ahmed, Dabney P. Evans, Benjamin Mason Meier, Aparna Nair
219 [GO] 2021―Aug―06 Neonatal care during the COVID-19 pandemic - a global survey of parents’ experiences regarding infant and family-centred developmental care Johanna Kostenzer, Julia Hoffmann, Charlotte von Rosenstiel-Pulver, Aisling Walsh, Luc J.I. Zimmermann, Silke Mader
220 [GO] 2021―Aug―06 Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization Avni Thakore, James Nguyen, Simcha Pollack, Stefan Muehlbauer, Benjamin Chi, Derek Knight, et al. (+5)
221 [GO] 2021―Aug―06 Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection Ivo M.B. Francischetti, Kevin Toomer, Yifan Zhang, Jayesh Jani, Zishan Siddiqui, Daniel J. Brotman, et al. (+2)
222 [GO] 2021―Aug―05 The foreseen loss of the battle against COVID-19 in South America: A foretold tragedy Monica Malta, Mario Vianna Vettore, Cosme Marcelo Furtado Passos da Silva, Angelica Baptista Silva, Steffanie A. Strathdee
223 [GO] 2021―Aug―03 Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic Peter J. Hotez, Carolina Batista, Yanis Ben Amor, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, et al. (+15)
224 [GO] 2021―Jul―31 The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence Aida Suárez-González, Jayeeta Rajagopalan, Gill Livingston, Suvarna Alladi
225 [GO] 2021―Jul―31 Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases Maxime Taquet, Masud Husain, John R Geddes, Sierra Luciano, Paul J Harrison
226 [GO] 2021―Jul―31 Obesity during COVID-19: An underrated pandemic? Giuseppe Grosso
227 [GO] 2021―Jul―31 Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study Dawit Wolday, Teklay Gebrecherkos, Zekarias Gessesse Arefaine, Yazezew Kebede Kiros, Atsbeha Gebreegzabher, Geremew Tasew, et al. (+15)
228 [GO] 2021―Jul―31 Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England Swapnil Mishra, Sören Mindermann, Mrinank Sharma, Charles Whittaker, Thomas A Mellan, Thomas Wilton, et al. (+24)
229 [GO] 2021―Jul―29 Reproductive health crisis during waves one and two of the COVID-19 pandemic in India: Incidence and deaths from severe maternal complications in more than 202,000 hospital births Manisha Nair
230 [GO] 2021―Jul―23 Cognitive deficits in people who have recovered from COVID-19 Adam Hampshire, William Trender, Samuel R Chamberlain, Amy E. Jolly, Jon E. Grant, Fiona Patrick, et al. (+5)
231 [GO] 2021―Jul―23 Letter to the editor in response to a letter by Deeks regarding Peto T; UK COVID-19 lateral flow oversight team: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay Lennard Y.W. Lee, Tim E. Peto
232 [GO] 2021―Jul―23 SARS-Cov-2 prevalence, transmission, health-related outcomes and control strategies in homeless shelters: Systematic review and meta-analysis Amir Mohsenpour, Kayvan Bozorgmehr, Sven Rohleder, Jan Stratil, Diogo Costa
233 [GO] 2021―Jul―23 A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India Upinder Kaur, Bisweswar Ojha, Bhairav Kumar Pathak, Anup Singh, Kiran R Giri, Amit Singh, et al. (+5)
234 [GO] 2021―Jul―19 Mask use in community settings in the context of COVID-19: A systematic review of ecological data Nathan Ford, Haley K. Holmer, Roger Chou, Paul J. Villeneuve, April Baller, Maria Van Kerkhove, Benedetta Allegranzi
235 [GO] 2021―Jul―17 Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities Rachelle P. Mendoza, Chongfeng Bi, Hui-Ting Cheng, Elmer Gabutan, Guillerre Jan Pagapas, Nadia Khan, et al. (+37)
236 [GO] 2021―Jul―17 Race, ethnicity, community-level socioeconomic factors, and risk of COVID-19 in the United States and the United Kingdom Chun-Han Lo, Long H. Nguyen, David A. Drew, Erica T. Warner, Amit D. Joshi, Mark S. Graham, et al. (+23)
237 [GO] 2021―Jul―17 Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India Taufik Momin, Kevinkumar Kansagra, Hardik Patel, Sunil Sharma, Bhumika Sharma, Jatin Patel, et al. (+10)
238 [GO] 2021―Jul―16 The impact of lockdown timing on COVID-19 transmission across US counties Xiaolin Huang, Xiaojian Shao, Li Xing, Yushan Hu, Don D. Sin, Xuekui Zhang
239 [GO] 2021―Jul―16 Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality Prof Cesar Victora, Prof Marcia C Castro, Susie Gurzenda, Arnaldo C Medeiros, Giovanny V A França, Prof Aluisio J D Barros
240 [GO] 2021―Jul―16 Pediatric BMI changes during COVID-19 pandemic: An electronic health record-based retrospective cohort study Corinne G. Brooks, Jessica R. Spencer, J. Michael Sprafka, Kimberly A. Roehl, Junjie Ma, Ajit A. Londhe, et al. (+4)
241 [GO] 2021―Jul―15 Letter to the Editor regarding Peto T; UK COVID-19 Lateral Flow Oversight Team: COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay Jonathan J Deeks, Jacqueline Dinnes, Clare Davenport, Yemisi Takwoingi, Matthew McInnes, Mariska MG Leeflang, Jane Cunningham
242 [GO] 2021―Jul―14 A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures Cécile Tran Kiem, Clément R. Massonnaud, Daniel Levy-Bruhl, Chiara Poletto, Vittoria Colizza, Paolo Bosetti, et al. (+7)
243 [GO] 2021―Jul―14 SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom Gareth H Williams, Alexander Llewelyn, Ruben Brandao, Kaiya Chowdhary, Keeda-Marie Hardisty, Marco Loddo
244 [GO] 2021―Jul―13 Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. Alexis R. Demonbreun, Amelia Sancilio, Matt P. Velez, Daniel T. Ryan, Rana Saber, Lauren A. Vaught, et al. (+6)
245 [GO] 2021―Jul―13 Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis Anand V. Kulkarni, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Candia, Karan Kumar, et al. (+4)
246 [GO] 2021―Jul―13 Renin Angiotensin System Inhibition as treatment for Covid-19? Professor Bryan Williams
247 [GO] 2021―Jul―13 Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) Werner Leber, Oliver Lammel, Andrea Siebenhofer, Monika Redlberger-Fritz, Jasmina Panovska-Griffiths, Thomas Czypionka
248 [GO] 2021―Jul―07 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial Wanshen Guo, Kai Duan, Yuntao Zhang, Zhiming Yuan, Yan-Bo Zhang, Zejun Wang, et al. (+32)
249 [GO] 2021―Jul―06 Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: A retrospective cohort study Meng Wang, Qiyu Yang, Xinling Ren, Juan Hu, Zhou Li, Rui Long, et al. (+3)
250 [GO] 2021―Jul―01 The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020 Elias Kondilis, Dimitris Papamichail, Sophie McCann, Elspeth Carruthers, Apostolos Veizis, Miriam Orcutt, Sally Hargreaves
251 [GO] 2021―Jun―27 Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial. Vinicius Fontanesi Blum, Sérgio Cimerman, James R Hunter, Paulo Tierno, Acioly Lacerda, Alexandre Soeiro, et al. (+11)
252 [GO] 2021―Jun―27 Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial Jean-Jacques Parienti, Thierry Prazuck, Laure Peyro-Saint-Paul, Anna Fournier, Cécile Valentin, Sylvie Brucato, et al. (+9)
253 [GO] 2021―Jun―27 Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study Mary K. Foley, Samuel D. Searle, Ali Toloue, Ryan Booth, Alec Falkenham, Darryl Falzarano, et al. (+13)
254 [GO] 2021―Jun―26 Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study Szu-Min Hsieh, Wang-Da Liu, Yu-Shan Huang, Yi-Jiun Lin, Erh-Fang Hsieh, Wei-Cheng Lian, et al. (+6)
255 [GO] 2021―Jun―23 Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review Cecilia Vindrola-Padros, Kelly E Singh, Manbinder S Sidhu, Theo Georghiou, Chris Sherlaw-Johnson, Sonila M Tomini, et al. (+5)
256 [GO] 2021―Jun―19 Global changes in maternity care provision during the COVID-19 pandemic: A systematic review and meta-analysis Rosemary Townsend, Barbara Chmielewska, Imogen Barratt, Erkan Kalafat, Jan van der Meulen, Ipek Gurol-Urganci, et al. (+9)
257 [GO] 2021―Jun―18 Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis Andrea Crafa, Rossella Cannarella, Rosita A. Condorelli, Laura M. Mongioì, Federica Barbagallo, Antonio Aversa, et al. (+2)
258 [GO] 2021―Jun―18 Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, Marina Travacio, Ricardo Valentini, Daniel F. Alonso, et al. (+17)
259 [GO] 2021―Jun―18 Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial Mariano Duarte, Facundo Pelorosso, Liliana N. Nicolosi, M. Victoria Salgado, Héctor Vetulli, Analía Aquieri, et al. (+11)
260 [GO] 2021―Jun―17 A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19 Michael A. Puskarich, Nathan W. Cummins, Nicholas E. Ingraham, David A. Wacker, Ronald A. Reilkoff, Brian E Driver, et al. (+13)
261 [GO] 2021―Jun―10 Ethnic inequalities in health: The interplay of racism and COVID-19 in syndemics Kamaldeep Bhui
262 [GO] 2021―Jun―10 Structural racism and risk of SARS-CoV-2 in pregnancy Rachel Pope, Prakash Ganesh, Jill Miracle, Romona Brazile, Honor Wolfe, Johnie Rose, et al. (+3)
263 [GO] 2021―Jun―10 Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis Zainab Alimoradi, Anders Broström, Hector W.H. Tsang, Mark D. Griffiths, Shahab Haghayegh, Maurice M. Ohayon, et al. (+2)
264 [GO] 2021―Jun―09 A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study Fredy Suter, Elena Consolaro, Stefania Pedroni, Chiara Moroni, Elena Pastò, Maria Vittoria Paganini, et al. (+8)
265 [GO] 2021―Jun―09 SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020 Shamez N Ladhani, Georgina Ireland, Frances Baawuah, Joanne Beckmann, Ifeanyichukwu O Okike, Shazaad Ahmad, et al. (+19)
266 [GO] 2021―Jun―09 Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values Alejandro Fernandez-Montero, Josepmaria Argemi, José Antonio Rodríguez, Arturo H. Ariño, Laura Moreno-Galarraga
267 [GO] 2021―Jun―07 Health and migration: Will migrants share the road to recovery from COVID-19? Zsuzsanna Jakab, Santino Severoni, Richard Alderslade, Kanokporn Kaojaroen, Rifat Hossain, Simona Melki
268 [GO] 2021―Jun―07 Operationalizing equity during local pandemic response Nathaniel Raymond, Andrew Chambers, David Polatty, Kaveh Khoshnood, Rachel Xu
269 [GO] 2021―Jun―06 Uncovering transmission patterns of COVID-19 outbreaks: A region-wide comprehensive retrospective study in Hong Kong Yang Liu, Zhonglei Gu, Jiming Liu
270 [GO] 2021―Jun―05 Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data Fares Qeadan, Benjamin Tingey, Rona Bern, Christina A Porucznik, Kevin English, Ali I. Saeed, Erin Fanning Madden
271 [GO] 2021―Jun―05 Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial Shaukat Ali, Syed Muneeb Uddin, Elisha Shalim, Muneeba Ahsan Sayeed, Fatima Anjum, Farah Saleem, et al. (+17)
272 [GO] 2021―Jun―05 Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine Raul Pellini, Aldo Venuti, Fulvia Pimpinelli, Elva Abril, Giovanni Blandino, Flaminia Campo, et al. (+23)
273 [GO] 2021―Jun―04 Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries Marliana S. Rejeki, Nana Sarnadi, Retno Wihastuti, Vininta Fazharyasti, Wisvici Y. Samin, Frilasita A. Yudhaputri, et al. (+4)
274 [GO] 2021―Jun―04 The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection Lindsay A. Thompson, Matthew J. Gurka, Stephanie L. Filipp, Desmond A. Schatz, Rebeccah E. Mercado, David A. Ostrov, et al. (+2)
275 [GO] 2021―Jun―04 The early impact of COVID-19 on primary care psychological therapy services: A descriptive time series of electronic healthcare records Clarissa Bauer-Staeb, Alice Davis, Theresa Smith, Wendy Wilsher, David Betts, Chris Eldridge, et al. (+3)
276 [GO] 2021―Jun―03 Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment Denise Naniche, Peter Hotez, Maria Elena Bottazzi, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, et al. (+14)
277 [GO] 2021―May―30 Rehabilitation needs and mortality associated with the Covid-19 pandemic: a population-based study of all hospitalised and home-healthcare individuals in a Swedish healthcare region Anestis Divanoglou, Assoc. Prof Kersti Samuelsson, Prof. Emer. Rune Sjödahl, Christer Andersson, Prof. Richard Levi
278 [GO] 2021―May―30 Second wave of COVID-19 pandemic in India: Barriers to effective governmental response Sujita Kumar Kar, Ramdas Ransing, S.M.Yasir Arafat, Vikas Menon
279 [GO] 2021―May―30 COVID-19 poses alarming pregnancy and postpartum mortality risk in Brazil Susie Gurzenda, Marcia C. Castro
280 [GO] 2021―May―30 COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing Tim Peto, Dominic Affron, Babak Afrough, Anita Agasu, Mark Ainsworth, Alison Allanson, et al. (+265)
281 [GO] 2021―May―29 Commentary regarding video-based telemedicine triage in emergency ophthalmology during COVID-19 Natasha Nayak Kolomeyer, Jonathan S. Myers
282 [GO] 2021―May―29 COVID-19 and migrant and refugee health: A pointer to system competence in future pandemic preparedness Stephen A Matlin, Miriam Orcutt, Ietza Bojorquez, Ozge Karadag Caman, Santino Severoni, Paul Spiegel, et al. (+2)
283 [GO] 2021―May―29 Ethnic minority and migrant underrepresentation in Covid-19 research: Causes and solutions Melanie Etti, Hazel Fofie, Mohammad Razai, Alison F. Crawshaw, Sally Hargreaves, Lucy P. Goldsmith
284 [GO] 2021―May―24 A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States David Alfego, Adam Sullivan, Brian Poirier, Jonathan Williams, Dorothy Adcock, Stanley Letovsky
285 [GO] 2021―May―23 Urgent needs to accelerate the race for COVID-19 therapeutics Carolina Batista, Shmuel Shoham, Onder Ergonul, Peter Hotez, Maria Elena Bottazzi, J. Peter Figueroa, et al. (+14)
286 [GO] 2021―May―23 Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis Stavroula Kastora, Georgios Kounidas, Sarah Perrott, Ben Carter, Jonathan Hewitt, Phyo Kyaw Myint
287 [GO] 2021―May―16 Prevalence and correlates of stress and burnout among U.S. healthcare workers during the COVID-19 pandemic: A national cross-sectional survey study Kriti Prasad, Colleen McLoughlin, Martin Stillman, Sara Poplau, Elizabeth Goelz, Sam Taylor, et al. (+6)
288 [GO] 2021―May―15 COVID-19 vaccination: Helping the latinx community to come forward Alejandro A. Diaz, Juan C. Celedón
289 [GO] 2021―May―07 Structural racism and social distancing: Implications for COVID-19 Renee Mehra, Linda S. Franck
290 [GO] 2021―May―07 The COVID-19 pandemic, Black mistrust, and a path forward E.A. Rusoja, B.A. Thomas
291 [GO] 2021―May―07 Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic Saro Abdella, Samuel Riou, Masresha Tessema, Ashenafi Assefa, Albab Seifu, Anna Blachman, et al. (+6)
292 [GO] 2021―May―06 Political neglect of COVID-19 and the public health consequences in Brazil: The high costs of science denial Monica Malta, Mario Vianna Vettore, Cosme Marcelo Furtado Passos da Silva, Angelica Baptista Silva, Steffanie A. Strathdee
293 [GO] 2021―May―03 A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients Ralph Wendt, Lutgarde Thijs, Sven Kalbitz, Harald Mischak, Justyna Siwy, Julia Raad, et al. (+17)
294 [GO] 2021―Apr―28 SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy Laith J. Abu-Raddad, Hiam Chemaitelly, Peter Coyle, Joel A. Malek, Ayeda A. Ahmed, Yasmin A. Mohamoud, et al. (+17)
295 [GO] 2021―Apr―27 The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin America Ganesh M. Babulal, Valeria L. Torres, Daisy Acosta, Cinthya Agüero, Sara Aguilar-Navarro, Rebecca Amariglio, et al. (+46)
296 [GO] 2021―Apr―26 An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C Amaro Nunes Duarte-Neto, Elia Garcia Caldini, Michele Soares Gomes-Gouvêa, Cristina Takami Kanamura, Renata Aparecida de Almeida Monteiro, Juliana Ferreira Ferranti, et al. (+13)
297 [GO] 2021―Apr―26 Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: A national observational study for the Getting It Right First Time Programme William K. Gray, Annakan V Navaratnam, Jamie Day, Pratusha Babu, Shona Mackinnon, Ini Adelaja, et al. (+18)
298 [GO] 2021―Apr―26 Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality Fardad Haghpanah, Gary Lin, Simon A. Levin, Eili Klein
299 [GO] 2021―Apr―25 The ROX index has greater predictive validity than NEWS2 for deterioration in Covid-19 Emma Prower, David Grant, Alessandra Bisquera, Cormac P Breen, Luigi Camporota, Maja Gavrilovski, et al. (+3)
300 [GO] 2021―Apr―25 Residential racial segregation and social distancing in the United States during COVID-19 Alexandre White, Lingxin Hao, Xiao Yu, Roland J. Thorpe
301 [GO] 2021―Apr―25 Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infection Radha Yadav, Arup Acharjee, Akanksha Salkar, Renuka Bankar, Viswanthram Palanivel, Sachee Agrawal, et al. (+3)
302 [GO] 2021―Apr―25 Complement inhibition in severe COVID-19 - Blocking C5a seems to be key: Author's reply Djillali Annane, Lamiae Grimaldi-Bensouda, Véronique Fremeaux-Bacchic
303 [GO] 2021―Apr―25 Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants Pratha Sah, Thomas N. Vilches, Seyed M. Moghadas, Meagan C. Fitzpatrick, Burton H. Singer, Peter J. Hotez, Alison P. Galvani
304 [GO] 2021―Apr―24 Complement inhibition in severe COVID-19 - Blocking C5a seems to be key Endry H.T. Lim, Alexander P.J. Vlaar, Sanne de-Bruin, Matthijs C. Brouwer, Diederik van-de-Beek
305 [GO] 2021―Apr―24 Specific COVID-19 messaging targeting ethnic minority communities Aftab Ala, Chantal Edge, Alimuddin Zumla, Shuja Shafi
306 [GO] 2021―Apr―23 Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy Ilaria Lega, Lorenza Nisticò, Luigi Palmieri, Emanuele Caroppo, Cinzia Lo Noce, Chiara Donfrancesco, et al. (+6)
307 [GO] 2021―Apr―22 Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. Jesper D. Gunst, Nina B. Staerke, Marie H. Pahus, Lena H. Kristensen, Jacob Bodilsen, Nicolai Lohse, et al. (+33)
308 [GO] 2021―Apr―19 Measuring the outsized impact of COVID-19 in the evolving setting of aged care facilities Marco Cassone, Lona Mody
309 [GO] 2021―Apr―19 A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR Xiangying Ren, Xiangge Ren, Jiaao Lou, Yongbo Wang, Qiao Huang, Yuexian Shi, et al. (+9)
310 [GO] 2021―Apr―16 COPD in the time of COVID-19 Peter M.A. Calverley
311 [GO] 2021―Apr―16 Reduced inflammatory responses to SARS-CoV-2 infection in children presenting to hospital with COVID-19 in China Guoqing Qian, Yong Zhang, Yang Xu, Weihua Hu, Ian P. Hall, Jiang Yue, et al. (+4)
312 [GO] 2021―Apr―16 Community-academic partnerships to reduce COVID-19 vaccine hesitancy in minoritized communities B. Peteet, J.C Belliard, J. Abdul-Mutakabbir, S. Casey, K. Simmons
313 [GO] 2021―Apr―16 Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019 Sylvia Ranjeva, Riccardo Pinciroli, Evan Hodell, Ariel Mueller, C.Corey Hardin, B.Taylor Thompson, Lorenzo Berra
314 [GO] 2021―Apr―16 Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. Ana M Valdes, James C Moon, Amrita Vijay, Nish Chaturvedi, Alan Norrish, Adeel Ikram, et al. (+14)
315 [GO] 2021―Apr―14 RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial Gustavo Lopardo, Waldo H. Belloso, Esteban Nannini, Mariana Colonna, Santiago Sanguineti, Vanesa Zylberman, et al. (+30)
316 [GO] 2021―Apr―07 Socio-demographic data collection and equity in covid-19 in Toronto Kwame McKenzie
317 [GO] 2021―Apr―07 The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19 Kevin E. McVaney, Paul E. Pepe, Lauren M. Maloney, E.Stein Bronsky, Remle P. Crowe, James J. Augustine, et al. (+7)
318 [GO] 2021―Apr―06 Safety of video-based telemedicine compared to in-person triage in emergency ophthalmology during COVID-19 Ji-Peng Olivia Li, Alice A.P. Thomas, Caroline L.S. Kilduff, Abison Logeswaran, Rishi Ramessur, Anton Jaselsky, et al. (+3)
319 [GO] 2021―Apr―06 Sexual violence and rapes’ increment during the COVID-19 pandemic in Bangladesh Firoj al Mamun, Ismail Hosen, Mohammed A. Mamun
320 [GO] 2021―Apr―06 An evaluation of the mental health impact of SARS-CoV-2 on patients, general public and healthcare professionals: A systematic review and meta-analysis Peter Phiri, Rema Ramakrishnan, Shanaya Rathod, Kathryn Elliot, Tony Thayanandan, Natasha Sandle, et al. (+9)
321 [GO] 2021―Mar―31 SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru Mary F. Reyes-Vega, M.Gabriela Soto-Cabezas, Fany Cárdenas, Kevin S. Martel, Andree Valle, Juan Valverde, et al. (+3)
322 [GO] 2021―Mar―30 COVID-19, conflict, and non-communicable diseases among refugees Amani Al-Oraibi, Laura B. Nellums, Kaushik Chattopadhyay
323 [GO] 2021―Mar―30 The implementation of remote home monitoring models during the COVID-19 pandemic in England Cecilia Vindrola-Padros, Manbinder S Sidhu, Theo Georghiou, Chris Sherlaw-Johnson, Kelly E Singh, Sonila M Tomini, et al. (+3)
324 [GO] 2021―Mar―30 Assessment of pulmonary arterial circulation 3 months after hospitalization for SARS-CoV-2 pneumonia: Dual-energy CT (DECT) angiographic study in 55 patients Martine Remy-Jardin, Louise Duthoit, Thierry Perez, Paul Felloni, Jean-Baptiste Faivre, Stéphanie Fry, et al. (+4)
325 [GO] 2021―Mar―29 The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children - A nationwide register study in Finland Marjut Haapanen, Marjo Renko, Miia Artama, Ilari Kuitunen
326 [GO] 2021―Mar―23 COVID-19 and health care workers burnout: A call for global action Dharam Kaushik
327 [GO] 2021―Mar―23 Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus Colin Pawlowski, AJ Venkatakrishnan, Eshwan Ramudu, Christian Kirkup, Arjun Puranik, Nikhil Kayal, et al. (+6)
328 [GO] 2021―Mar―20 COVID-19 and the new variant strain in England - What are the implications for those from ethnic minority groups? Daniel Pan, Shirley Sze, Christopher A Martin, Clareece R Nevill, Jatinder S Minhas, Pip Divall, et al. (+6)
329 [GO] 2021―Mar―20 Negative impact of the first COVID-19 lockdown upon health-related behaviours and psychological wellbeing in people living with severe and complex obesity in the UK Adrian Brown, Stuart W. Flint, Anastasia Z. Kalea, Mary O'Kane, Simon Williams, Rachel L. Batterham
330 [GO] 2021―Mar―20 COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis Firoozeh V. Gerayeli, Stephen Milne, Chung Cheung, Xuan Li, Cheng Wei Tony Yang, Anthony Tam, et al. (+3)
331 [GO] 2021―Mar―10 Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients Colin Pawlowski, AJ Venkatakrishnan, Christian Kirkup, Gabriela Berner, Arjun Puranik, John C. O'Horo, et al. (+2)
332 [GO] 2021―Mar―09 Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis Ahmed Hossain, Sarker Mohammad Nasrullah, Zarrin Tasnim, Md.Kamrul Hasan, Md.Maruf Hasan
333 [GO] 2021―Mar―07 Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin Matt Spick, Katherine Longman, Cecile Frampas, Holly Lewis, Catia Costa, Deborah Dunn Walters, et al. (+8)
334 [GO] 2021―Mar―07 Correcting COVID-19 vaccine misinformation Peter Hotez, Carolina Batista, Onder Ergonul, J Peter Figueroa, Sarah Gilbert, Mayda Gursel, et al. (+12)
335 [GO] 2021―Mar―01 Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis Mohammad Rashidul Hashan, Nicolas Smoll, Catherine King, Hannah Ockenden-Muldoon, Jacina Walker, Andre Wattiaux, et al. (+3)
336 [GO] 2021―Feb―27 Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial Christine Johnston, Elizabeth R. Brown, Jenell Stewart, Helen C.Stankiewicz Karita, Patricia J. Kissinger, John Dwyer, et al. (+24)
337 [GO] 2021―Feb―26 Racial disparities in COVID-19 mortality across Michigan, United States Alyssa S. Parpia, Isabel Martinez, Abdulrahman M. El-Sayed, Chad R. Wells, Lindsey Myers, Jeffrey Duncan, et al. (+4)
338 [GO] 2021―Feb―26 Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scores Christopher J. Nicholson, Luke Wooster, Haakon H. Sigurslid, Rebecca H. Li, Wanlin Jiang, Wenjie Tian, et al. (+2)
339 [GO] 2021―Feb―26 Inoculating against COVID-19 vaccine misinformation Sander van der Linden, Graham Dixon, Chris Clarke, John Cook
340 [GO] 2021―Feb―24 Pregnant during the pandemic: United in motherhood Yalda Afshar, Jacqueline G. Parchem
341 [GO] 2021―Feb―23 Medical vulnerability of individuals with down syndrome to severe COVID-19 - data from the trisomy 21 research society and the UK ISARIC4C survey Anke Hüls, Alberto C.S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole T. Baumer, et al. (+16)
342 [GO] 2021―Feb―21 Executive summary: It's wrong not to test: The case for universal, frequent rapid COVID-19 testing Maureen Johnson-León, Arthur L. Caplan, Louise Kenny, Iain Buchan, Leah Fesi, Phoebe Olhava, et al. (+9)
343 [GO] 2021―Feb―16 Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensity-score analysis Carlos K.H. Wong, Eric Y.F. Wan, Sihui Luo, Yu Ding, Eric H.Y. Lau, Ping Ling, et al. (+7)
344 [GO] 2021―Feb―16 Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection Nicole Minckas, Melissa M. Medvedev, Ebunoluwa A. Adejuyigbe, Helen Brotherton, Harish Chellani, Abiy Seifu Estifanos, et al. (+18)
345 [GO] 2021―Feb―11 The importance of community engagement on COVID-19 vaccination strategy: Lessons from two California pilot programs Agastya Mondal
346 [GO] 2021―Feb―11 Can existing unrelated vaccines boost a COVID-19 vaccine prime? Nathaniel Hupert, Daniela Marín-Hernández, Douglas F. Nixon
347 [GO] 2021―Feb―11 Antibody titers against SARS-CoV-2 decline, but do not disappear for several months Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, Osamu Akasaka, Morio Nakamura, Ichiro Nakachi, et al. (+29)
348 [GO] 2021―Feb―11 Cholera during COVID-19: The forgotten threat for forcibly displaced populations Osama B Hassan, Laura B Nellums
349 [GO] 2021―Feb―07 Prioritizing COVID-19 vaccinations for individuals with intellectual and developmental disabilities Emily Hotez, Peter J. Hotez, Kashia A. Rosenau, Alice A. Kuo
350 [GO] 2021―Feb―07 It's all in the details: A call for administering the COVID-19 vaccine in Lebanon through a transparent and un-politicized collaborative approach Shadi Saleh, Hady Naal, Ali H. Mokdad
351 [GO] 2021―Feb―06 Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis? Céleo Ramírez, Edwin F. Herrera-Paz, Guímel Peralta, Gaspar Rodríguez, Reyna M. Durón
352 [GO] 2021―Jan―28 Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach M.A. de Graaf, M.L. Antoni, M.M. ter Kuile, M.S. Arbous, A.J.F. Duinisveld, M.C.W. Feltkamp, et al. (+17)
353 [GO] 2021―Jan―28 Climate change and COVID-19: global challenges and opportunities
354 [GO] 2021―Jan―19 The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, Iñigo Pineda, Alejandro Fernandez-Montero, Paula Ruiz-Castillo, et al. (+18)
355 [GO] 2021―Jan―18 Addressing public health's failings during year one of Covid-19 George J. Annas, Sandro Galea
356 [GO] 2021―Jan―18 Exposome changes in primary school children following the wide population non-pharmacological interventions implemented due to COVID-19 in Cyprus: A national survey Corina Konstantinou, Xanthi D. Andrianou, Andria Constantinou, Anastasia Perikkou, Eliza Markidou, Costas A. Christophi, Konstantinos C. Makris
357 [GO] 2021―Jan―18 Systemic racism and overcoming my COVID-19 vaccine hesitancy Lauren D. Nephew
358 [GO] 2021―Jan―10 Local measures enable COVID-19 containment with fewer restrictions due to cooperative effects Philip Bittihn, Lukas Hupe, Jonas Isensee, Ramin Golestanian
359 [GO] 2021―Jan―10 Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections Narendra Kumar, Shafeeq K. Shahul Hameed, Giridhara R. Babu, Manjunatha M. Venkataswamy, Prameela Dinesh, Prakash Kumar BG, et al. (+3)
360 [GO] 2021―Jan―10 Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge Betty Raman, Mark Philip Cassar, Elizabeth M. Tunnicliffe, Nicola Filippini, Ludovica Griffanti, Fidel Alfaro-Almagro, et al. (+43)
361 [GO] 2021―Jan―10 Biology, behavior and policy, or, Dr. Fauci, Sen. Paul and Prof. Lucas walk into a pandemic Ayse Ercumen, Raymond Guiteras, Dean Spears
362 [GO] 2020―Dec―25 Letter regarding 'Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis' Richard Armitage
363 [GO] 2020―Dec―25 Authors’ reply: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis Daniel Pan, Shirley Sze, Clareece R Nevill, Laura B Nellums, Manish Pareek
364 [GO] 2020―Dec―24 Letter response to the brain after COVID-19: Compensatory neurogenesis or persistent neuroinflammation? Yiping Lu, Xuanxuan Li, Daoying Geng, Nan Mei, Pu-Yeh Wu, Chu-Chung Huang, et al. (+5)
365 [GO] 2020―Dec―24 The brain after COVID-19: Compensatory neurogenesis or persistent neuroinflammation? Elkhonon Goldberg, Kenneth Podell, Daniel K. Sodickson, Els Fieremans
366 [GO] 2020―Dec―24 Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial Pablo Tebas, ShuPing Yang, Jean D. Boyer, Emma L. Reuschel, Ami Patel, Aaron Christensen-Quick, et al. (+31)
367 [GO] 2020―Dec―23 Cyclosporine A and COVID-19 - The COQUIMA cohort Macé M. Schuurmans, René Hage
368 [GO] 2020―Dec―23 Prioritizing incarcerated populations for COVID-19 vaccination and vaccine trials Nadine Kronfli, Matthew J. Akiyama
369 [GO] 2020―Dec―22 COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States QuanQiu Wang, Pamela B Davis, Rong Xu
370 [GO] 2020―Dec―08 The challenges of distributing COVID-19 vaccinations Melinda C. Mills, David Salisbury
371 [GO] 2020―Dec―05 Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection Hendrik Gremmels, Beatrice M.F. Winkel, Rob Schuurman, Andert Rosingh, Nicolette A.M. Rigter, Olga Rodriguez, et al. (+4)
372 [GO] 2020―Nov―30 The "sex gap" in COVID-19 trials: a scoping review Veronique M.M.M. Schiffer, Emma B.N.J. Janssen, Bas C.T. van Bussel, Laura L.M. Jorissen, Jeanette Tas, Jan-Willem E.M. Sels, et al. (+14)
373 [GO] 2020―Nov―30 Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data Helena Carreira, Helen Strongman, Maria Peppa, Helen I McDonald, Isabel dos-Santos-Silva, Susannah Stanway, et al. (+2)
374 [GO] 2020―Nov―29 COVID-19 and impairment of spermatogenesis: Implications drawn from pathological alterations in testicles and seminal parameters Mohammad Ishraq Zafar, Honggang Li
375 [GO] 2020―Nov―29 Covid-19 and impairment of spermatogenesis: What if fever was the only cause? M. Bendayan, F. Boitrelle
376 [GO] 2020―Nov―25 Caring for people who care: supporting health workers during the COVID 19 pandemic
377 [GO] 2020―Nov―20 Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 Ali S. Omrani, Sameer A. Pathan, Sarah A. Thomas, Tim R.E. Harris, Peter V. Coyle, Caroline E. Thomas, et al. (+13)
378 [GO] 2020―Nov―20 Results from the SERPICO-19 study - the role of retinal evaluation and in vivo vascular assessment in COVID-19 Paula M. Marinho, Allexya A.A. Marcos, Ana Marisa P. Castello Branco, Victoria Sakamoto, André Romano, Paulo Schor, et al. (+3)
379 [GO] 2020―Nov―20 Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis Mahmoud B. Malas, Isaac N. Naazie, Nadin Elsayed, Asma Mathlouthi, Rebecca Marmor, Bryan Clary
380 [GO] 2020―Nov―20 Social media, ageism, and older adults during the COVID-19 pandemic Enrique Soto-Perez-de-Celis
381 [GO] 2020―Nov―20 Applying the lessons of COVID-19 response to Canada's worsening opioid epidemic Alexa Norton, Thomas Kerr
382 [GO] 2020―Nov―20 Here, the huge rainbow within the COVID-19 storm Ilaria Capua, Mario Rasetti
383 [GO] 2020―Nov―20 Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations Rahul Chaudhary, Kevin P. Bliden, Rolf P. Kreutz, Young-Hoon Jeong, Udaya S. Tantry, Jerrold H. Levy, Paul A. Gurbel
384 [GO] 2020―Nov―20 Affected olfaction in COVID-19: Re-defining “asymptomatic” Jingwen Li, Xinyi Wang, Chunli Zhu, Zhicheng Lin, Nian Xiong
385 [GO] 2020―Nov―20 Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation Kfir Oved, Liraz Olmer, Yonat Shemer-Avni, Tamar Wolf, Lia Supino-Rosin, George Prajgrod, et al. (+21)
386 [GO] 2020―Nov―12 Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis Shirley Sze, Daniel Pan, Clareece R. Nevill, Laura J. Gray, Christopher A. Martin, Joshua Nazareth, et al. (+6)
387 [GO] 2020―Nov―06 Mechanical ventilation in early COVID-19 ARDS Philipp M. Lepper, Ralf M. Muellenbach
388 [GO] 2020―Nov―06 COVID-19 risk tools should incorporate assessment of working environment risk and its mitigation Tim M. Cook, Kariem El-Boghdadly
389 [GO] 2020―Nov―06 High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England Shamez N Ladhani, Anna Jeffery-Smith, Monika Patel, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, et al. (+22)
390 [GO] 2020―Nov―05 Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study Djillali Annane, Nicholas Heming, Lamiae Grimaldi-Bensouda, Véronique Frémeaux-Bacchi, Marie Vigan, Anne-Laure Roux, et al. (+4)
391 [GO] 2020―Nov―05 Factors affecting the mortality of patients with COVID-19 undergoing surgery and the safety of medical staff: A systematic review and meta-analysis Kun Wang, Changshuai Wu, Jian Xu, Baohui Zhang, Xiaowang Zhang, Zhenglian Gao, Zhengyuan Xia
392 [GO] 2020―Oct―28 Dear Mr. President, you can't lie your way out of this pandemic!
393 [GO] 2020―Oct―27 COVID-19, health disparities and the US election Keith Norris, Cynthia Gonzalez
394 [GO] 2020―Oct―24 Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study Dorota M Ruszkiewicz, Daniel Sanders, Rachel O'Brien, Frederik Hempel, Matthew J Reed, Ansgar C Riepe, et al. (+12)
395 [GO] 2020―Oct―24 The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis Lucia Cilloni, Han Fu, Juan F Vesga, David Dowdy, Carel Pretorius, Sevim Ahmedov, et al. (+5)
396 [GO] 2020―Oct―23 Impaired spermatogenesis in COVID-19 patients Honggang Li, Xingyuan Xiao, Jie Zhang, Mohammad Ishraq Zafar, Chunlin Wu, Yuting Long, et al. (+9)
397 [GO] 2020―Oct―17 My journey with COVID-19 Monica Malta
398 [GO] 2020―Oct―16 Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers Anindya S. Bhattacharjee, Samir V. Joshi, Shilpa Naik, Shashikala Sangle, Nixon M. Abraham
399 [GO] 2020―Oct―15 Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort) Pablo Guisado-Vasco, Sofia Valderas-Ortega, Maria Maravillas Carralón-González, Ana Roda-Santacruz, Lucia González-Cortijo, Gabriel Sotres-Fernández, et al. (+19)
400 [GO] 2020―Oct―13 Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study Sylvain Lamure, Rémy Duléry, Roberta Di Blasi, Adrien Chauchet, Cécile Laureana, Bénédicte Deau-Fischer, et al. (+16)
401 [GO] 2020―Oct―11 Evaluation of PEEP and prone positioning in early COVID-19 ARDS Mirja Mittermaier, Philipp Pickerodt, Florian Kurth, Laure Bosquillon de Jarcy, Alexander Uhrig, Carmen Garcia, et al. (+14)
402 [GO] 2020―Oct―10 Tuberculosis and COVID-19 in Canada Richard Long, Malcolm King, Alexander Doroshenko, Courtney Heffernan
403 [GO] 2020―Oct―09 A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19 Rosita Zakeri, Rebecca Bendayan, Mark Ashworth, Daniel M. Bean, Hiten Dodhia, Stevo Durbaba, et al. (+12)
404 [GO] 2020―Oct―06 The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study Gregory L. Calligaro, Usha Lalla, Gordon Audley, Phindile Gina, Malcolm G. Miller, Marc Mendelson, et al. (+17)
405 [GO] 2020―Oct―05 Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study Filippo Albani, Lilia Sepe, Federica Fusina, Chiara Prezioso, Manuela Baronio, Federica Caminiti, et al. (+6)
406 [GO] 2020―Oct―02 Sarilumab use in severe SARS-CoV-2 pneumonia Elisa Gremese, Antonella Cingolani, Silvia Laura Bosello, Stefano Alivernini, Barbara Tolusso, Simone Perniola, et al. (+35)
407 [GO] 2020―Sep―30 Understanding the long-term health effects of COVID-19
408 [GO] 2020―Sep―24 Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020 Jianbin Li, Haibo Wang, Cuizhi Geng, Zhenzhen Liu, Ying Lin, Jianyun Nie, et al. (+24)
409 [GO] 2020―Sep―21 The characteristics of COVID-19 transmission from case to high-risk contact, a statistical analysis from contact tracing data Chayanon Phucharoen, Nichapat Sangkaew, Kristina Stosic
410 [GO] 2020―Sep―20 An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 Weihui Fu, Yan Liu, Li Liu, Huiliang Hu, Xiaobo Cheng, Ping Liu, et al. (+17)
411 [GO] 2020―Sep―20 Impact of COVID-19 pandemic on clinical and surgical breast cancer management Paolo Veronesi, Giovanni Corso
412 [GO] 2020―Sep―20 The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study Abderrahim Oussalah, Stanislas Gleye, Isabelle Clerc Urmes, Elodie Laugel, Françoise Barbé, Sophie Orlowski, et al. (+18)
413 [GO] 2020―Sep―20 Retinal findings in patients with COVID-19: Results from the SERPICO-19 study Alessandro Invernizzi, Alessandro Torre, Salvatore Parrulli, Federico Zicarelli, Marco Schiuma, Valeria Colombo, et al. (+14)
414 [GO] 2020―Sep―20 The epidemiology and pathogenesis of SARS-CoV-2 infection in pregnancy: More questions than answers Jasantha Odayar, Landon Myer, Thokozile R. Malaba
415 [GO] 2020―Sep―19 COVID-19 in COPD: A growing concern Don D. Sin
416 [GO] 2020―Sep―19 Towards characterized convalescent plasma for COVID-19: The dose matters Hans P. Verkerke, Cheryl L. Maier
417 [GO] 2020―Sep―15 Host tolerance contributes to persistent viral shedding in COVID-19 De Chang, Zhu Chen, Fu-Sheng Wang, Li-Xin Xie, Charles S. Dela Cruz, Lokesh Sharma, En-Qiang Qin
418 [GO] 2020―Sep―15 Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey Fuling Zhou, Jingfeng Li, Mengxin Lu, Linlu Ma, Yunbao Pan, Xiaoyan Liu, et al. (+10)
419 [GO] 2020―Sep―09 A COVID-19 exemption code to ensure post-recovery care: From the territory a proposal for the Apulia Region government Emanuele Rizzo, Simona Carlà, Salvatore Ruggeri
420 [GO] 2020―Sep―09 Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey Javier Martínez-Sanz, José A. Pérez-Molina, Santiago Moreno, Javier Zamora, Sergio Serrano-Villar
421 [GO] 2020―Sep―09 Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma Yasmin Maor, Daniel Cohen, Nir Paran, Tomer Israely, Vered Ezra, Ofra Axelrod, et al. (+19)
422 [GO] 2020―Sep―09 Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020 Shamez N Ladhani, J.Yimmy Chow, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, Amoolya Vusirikala, et al. (+24)
423 [GO] 2020―Sep―03 COVID-19 and older adults: more support is needed
424 [GO] 2020―Aug―26 Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19 Sachin J. Shah, Peter N. Barish, Priya A. Prasad, Amy Kistler, Norma Neff, Jack Kamm, et al. (+39)
425 [GO] 2020―Aug―26 SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry Amy A Attaway, Joe Zein, Umur S Hatipoğlu
426 [GO] 2020―Aug―25 Differentiating diagnosis of COVID-19 or influenza in patients based on laboratory data during flu season Shuwen Liu, Chungen Pan
427 [GO] 2020―Aug―25 Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis Robin Park, Anusha Chidharla, Kathan Mehta, Weijing Sun, Elizabeth Wulff-Burchfield, Anup Kasi
428 [GO] 2020―Aug―25 Fighting pandemics with digital epidemiology Sasu Tarkoma, Suliman Alghnam, Michael D. Howell
429 [GO] 2020―Aug―24 Delirium: A suggestive sign of COVID-19 in dementia Huali Wang
430 [GO] 2020―Aug―24 Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China Hua Ye, Chengguang Zhao, Lehe Yang, Wenwen Yu, Zhefeng Leng, Yangjie Sun, et al. (+8)
431 [GO] 2020―Aug―24 Time from COVID-19 shutdown, gender-based violence exposure, and mental health outcomes among a state representative sample of California residents Anita Raj, Nicole E. Johns, Kathryn M. Barker, Jay G. Silverman
432 [GO] 2020―Aug―19 Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system Cian P. McCarthy, Sean Murphy, Maeve Jones-O'Connor, David S. Olshan, Jay R. Khambhati, Saad Rehman, et al. (+14)
433 [GO] 2020―Aug―19 COVID-19: Risk factors for critical illness Yadong Gao
434 [GO] 2020―Aug―18 Mass vaccination against COVID-19 may require replays of the polio vaccination drives Manju Rahi, Amit Sharma
435 [GO] 2020―Aug―18 Country level analysis of COVID-19 policies Joost Hopman, Shaheen Mehtar
436 [GO] 2020―Aug―18 Preparing for a COVID-19 surge: ICUs Manar Alkuzweny, Anita Raj, Sanjay Mehta
437 [GO] 2020―Aug―17 Risk factors for detection of SARS-CoV-2 in healthcare workers during April 2020 in a UK hospital testing programme John S Leeds, Veena Raviprakash, Thomas Jacques, Noel Scanlon, Jeremy Cundall, Clare M Leeds
438 [GO] 2020―Aug―12 Some challenges of sparse data necessitating strong assumptions in investigating early COVID-19 disease John Norrie
439 [GO] 2020―Aug―12 Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle, US Zhanwei Du, Emily Javan, Ciara Nugent, Benjamin J. Cowling, Lauren Ancel Meyers
440 [GO] 2020―Aug―12 Determinants of COVID-19 vaccine acceptance in the US Amyn A. Malik, SarahAnn M. McFadden, Jad Elharake, Saad B. Omer
441 [GO] 2020―Aug―03 Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study Yiping Lu, Xuanxuan Li, Daoying Geng, Nan Mei, Pu-Yeh Wu, Chu-Chung Huang, et al. (+5)
442 [GO] 2020―Jul―31 Race, COVID-19 and deaths of despair Patrick J. Arena, Monica Malta, Anne W. Rimoin, Steffanie A. Strathdee
443 [GO] 2020―Jul―31 Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: A modelling study Britta L. Jewell, Jennifer A. Smith, Timothy B. Hallett
444 [GO] 2020―Jul―31 Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza Yang Mei, Samuel E. Weinberg, Lihui Zhao, Adam Frink, Chao Qi, Amir Behdad, Peng Ji
445 [GO] 2020―Jul―30 Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study Tino Emanuele Poloni, Arenn Faye Carlos, Marco Cairati, Chiara Cutaia, Valentina Medici, Eleonora Marelli, et al. (+11)
446 [GO] 2020―Jul―30 Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study Dan Liu, Pengfei Cui, Shaoqing Zeng, Siyuan Wang, Xinxia Feng, Sen Xu, et al. (+18)
447 [GO] 2020―Jul―29 A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 Weihui Fu, Yan Liu, Lu Xia, Min Li, Zhigang Song, Huiliang Hu, et al. (+17)
448 [GO] 2020―Jul―29 A vaccine for SARS-CoV-2: goals and promises
449 [GO] 2020―Jul―24 COVID-19 and medical liability: Italy denies the shield to its heroes Ernesto d'Aloja, Gabriele Finco, Roberto Demontis, Pietro Emanuele Napoli, Maurizio Fossarello, Matteo Nioi
450 [GO] 2020―Jul―24 Coronavirus in Brazil: The heavy weight of inequality and unsound leadership Monica Malta, Laura Murray, Cosme Marcelo Furtado Passos da Silva, Steffanie A Strathdee
451 [GO] 2020―Jul―24 SARS-CoV-2 and human reproduction: An open question Frida Entezami, Marise Samama, Nathalie Dejucq-Rainsford, Louis Bujan
452 [GO] 2020―Jul―21 A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes Rabail Chaudhry, George Dranitsaris, Talha Mubashir, Justyna Bartoszko, Sheila Riazi
453 [GO] 2020―Jul―17 Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study Christopher A. Martin, David R. Jenkins, Jatinder S. Minhas, Laura J. Gray, Julian Tang, Caroline Williams, et al. (+13)
454 [GO] 2020―Jul―17 Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up Nicola De Rossi, Cristina Scarpazza, Chiara Filippini, Cinzia Cordioli, Sarah Rasia, Chiara Rosa Mancinelli, et al. (+13)
455 [GO] 2020―Jul―16 Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia Yojana Gokhale, Rakshita Mehta, Nitin Karnik, Uday Kulkarni, Sushant Gokhale
456 [GO] 2020―Jul―15 A novel scoring system in mortality prediction of severe patients with COVID-19 Anwen Shao, Yunxiang Zhou, Sheng Tu, Jifang Sheng
457 [GO] 2020―Jul―15 The association of race and COVID-19 mortality Ladan Golestaneh, Joel Neugarten, Molly Fisher, Henny H. Billett, Morayma Reyes Gil, Tanya Johns, et al. (+8)
458 [GO] 2020―Jul―15 Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery Yu-miao Zhao, Yao-min Shang, Wen-bin Song, Qing-quan Li, Hua Xie, Qin-fu Xu, et al. (+7)
459 [GO] 2020―Jul―14 COVID-19 experience in Kuwait: A high prevalence of asymptomatic cases and increased mortality in smokers Awadhesh Kumar Singh
460 [GO] 2020―Jul―13 Lockdown timing and efficacy in controlling COVID-19 using mobile phone tracking Marco Vinceti, Tommaso Filippini, Kenneth J. Rothman, Fabrizio Ferrari, Alessia Goffi, Giuseppe Maffeis, Nicola Orsini
461 [GO] 2020―Jul―10 Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study Fermín Sánchez-Guijo, Mariano García-Arranz, Miriam López-Parra, Pablo Monedero, Carmen Mata-Martínez, Arnoldo Santos, et al. (+18)
462 [GO] 2020―Jul―06 Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort Pedro David Wendel Garcia, Thierry Fumeaux, Philippe Guerci, Dorothea Monika Heuberger, Jonathan Montomoli, Ferran Roche-Campo, et al. (+2)
463 [GO] 2020―Jul―04 Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait Sulaiman Almazeedi, Sarah Al-Youha, Mohammad H. Jamal, Mohannad Al-Haddad, Ali Al-Muhaini, Fahad Al-Ghimlas, Salman Al-Sabah
464 [GO] 2020―Jul―03 Scoring systems for predicting mortality for severe patients with COVID-19 Yufeng Shang, Tao Liu, Yongchang Wei, Jingfeng Li, Liang Shao, Minghui Liu, et al. (+6)
465 [GO] 2020―Jul―03 SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes Asma Khalil, Erkan Kalafat, Can Benlioglu, Pat O'Brien, Edward Morris, Tim Draycott, et al. (+6)
466 [GO] 2020―Jul―01 Subcutaneous tocilizumab treatment in patients with severe COVID-19-related cytokine release syndrome: An observational cohort study Antonio Mastroianni, Sonia Greco, Giovanni Apuzzo, Salvatore De Santis, Carmela Oriolo, Alfredo Zanolini, et al. (+2)
467 [GO] 2020―Jun―29 Prioritising mental health after the pandemic
468 [GO] 2020―Jun―27 When pandemics clash: Gendered violence-related traumatic brain injuries in women since COVID-19 Eve M. Valera
469 [GO] 2020―Jun―27 Frontline nurses’ burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study Deying HU, Yue KONG, Wengang LI, Qiuying HAN, Xin ZHANG, Li Xia ZHU, et al. (+6)
470 [GO] 2020―Jun―27 The resilience of Taiwan's health system to address the COVID-19 pandemic Emeline Han, Shu-Ti Chiou, Martin McKee, Helena Legido-Quigley
471 [GO] 2020―Jun―27 Eosinopenia and COVID-19 patients: So specific ? Fabio Andreozzi, Cedric Hermans, Jean Cyr Yombi
472 [GO] 2020―Jun―26 COVID-19 in 7780 pediatric patients: A systematic review Ansel Hoang, Kevin Chorath, Axel Moreira, Mary Evans, Finn Burmeister-Morton, Fiona Burmeister, et al. (+3)
473 [GO] 2020―Jun―25 Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series Amy V. Rapkiewicz, Xingchen Mai, Steven E. Carsons, Stefania Pittaluga, David E. Kleiner, Jeffrey S. Berger, et al. (+6)
474 [GO] 2020―Jun―24 Whistleblowing and patient safety during COVID-19 Richard Armitage, Laura B Nellums
475 [GO] 2020―Jun―24 COVID-19 in Wuhan: Sociodemographic characteristics and hospital support measures associated with the immediate psychological impact on healthcare workers Zhou Zhu, Shabei Xu, Hui Wang, Zheng Liu, Jianhong Wu, Guo Li, et al. (+10)
476 [GO] 2020―Jun―20 Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study Tariq Kewan, Fahrettin Covut, Mohammed J. Al-Jaghbeer, Lori Rose, K.V. Gopalakrishna, Bassel Akbik
477 [GO] 2020―Jun―18 Eosinopenia as an early diagnostic marker of COVID-19 at the time of the epidemic Zhengyuan Xia
478 [GO] 2020―Jun―18 The disproportionate effect of COVID-19 mortality on ethnic minorities: Genetics or health inequalities? Ziad El-Khatib, Graeme Brendon Jacobs, George Mondinde Ikomey, Ujjwal Neogi
479 [GO] 2020―Jun―18 Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation Andrea Duca, Irdi Memaj, Federico Zanardi, Carlo Preti, Andrea Alesi, Lorenzo Della Bella, et al. (+6)
480 [GO] 2020―Jun―15 Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain Rafael San-Juan, Patricia Barbero, Mario Fernández-Ruiz, Francisco López-Medrano, Manuel Lizasoáin, Pilar Hernández-Jiménez, et al. (+13)
481 [GO] 2020―Jun―06 COVID-19: Compounding the health-related harms of human trafficking Richard Armitage, Laura B Nellums
482 [GO] 2020―Jun―05 Preparing for a COVID-19 surge Manar Alkuzweny, Anita Raj, Sanjay Mehta
483 [GO] 2020―Jun―04 Governments and international institutions should urgently attend to the unjust disparities that COVID-19 is exposing and causing Luis Alberto Martinez-Juarez, Ana Cristina Sedas, Miriam Orcutt, Raj Bhopal
484 [GO] 2020―Jun―03 The impact of ethnicity on clinical outcomes in COVID-19: A systematic review Daniel Pan, Shirley Sze, Jatinder S. Minhas, Mansoor N. Bangash, Nilesh Pareek, Pip Divall, et al. (+7)
485 [GO] 2020―Jun―02 Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 Aakash Desai, Bishal Gyawali
486 [GO] 2020―May―24 Data explosion during COVID-19: A call for collaboration with the tech industry & data scrutiny Elizabeth M. Hechenbleikner, Daniel V. Samarov, Ed Lin
487 [GO] 2020―May―19 The 2019-nCoV pandemic in the global south: A Tsunami ahead Monica Malta, Anne W. Rimoin, Nicole A. Hoff, Steffanie A. Strathdee
488 [GO] 2020―May―17 Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. What are the implications for the commencement of elective surgery? Gary L Ross
489 [GO] 2020―May―17 Can we operate our patients without fear during the period of COVID-19 infection? Jean-Jacques Tuech, Lilian Schwarz
490 [GO] 2020―May―17 The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA Alison P. Galvani, Alyssa S. Parpia, Abhishek Pandey, Charlotte Zimmer, James G. Kahn, Meagan C. Fitzpatrick
491 [GO] 2020―May―11 COVID-19: Challenges and opportunities in the care sector Paulina Cecula, Sir David Behan, Dr Mahiben Maruthappu
492 [GO] 2020―May―05 Pandemic-related excess mortality (COVID-19), public health measures and funerary rituals Eric Crubézy, Norbert Telmon
493 [GO] 2020―May―03 COVID-19 and Healthcare worker's families: behind the scenes of frontline response Amine Souadka, Hajar Essangri, Amine Benkabbou, Laila Amrani, Mohammed Anass Majbar
494 [GO] 2020―May―03 Testing for COVID-19 in patients with cancer Omar Alhalabi, Swami Iyer, Vivek Subbiah
495 [GO] 2020―May―03 Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study Qilin Li, Xiuli Ding, Geqing Xia, Heng-Gui Chen, Fenghua Chen, Zhi Geng, et al. (+5)
496 [GO] 2020―May―01 Serosurveys and convalescent plasma in COVID-19 Cristina Pérez-Cameo, Juan Marín-Lahoz
497 [GO] 2020―Apr―29 Author's reply - Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Shaoqing Lei, Fang Jiang, Zhong-yuan Xia, Zhengyuan Xia
498 [GO] 2020―Apr―27 Covid-19 and perioperative mortality; where do we stand? Behnam Shakiba, Shirin Irani
499 [GO] 2020―Apr―27 Letter to the Editor: “Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection” Fabrizio Di Maida, Alessandro Antonelli, Angelo Porreca, Bernardo Rocco, Andrea Mari, Andrea Minervini
500 [GO] 2020―Apr―24 A reality check on the use of face masks during the COVID-19 outbreak in Hong Kong C.W. TAM Victor, Yau TAM Shing, Kwong POON Wai, K.W. LAW Helen, W.Y. LEE Shara
501 [GO] 2020―Apr―23 Age, frailty and diabetes - triple jeopardy for vulnerability to COVID-19 infection A.J. Sinclair, A.H. Abdelhafiz
502 [GO] 2020―Apr―22 SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV Paul K. Drain, Nigel Garrett
503 [GO] 2020―Apr―18 What are the Underlying Transmission Patterns of COVID-19 Outbreak? - An Age-specific Social Contact Characterization Y. Liu, Z. Gu, S. Xia, B. Shi, X.-N. Zhou, Y. Shi, J. Liu
504 [GO] 2020―Apr―11 COVID-19: Reducing the risk of infection might increase the risk of intimate partner violence N. van Gelder, A Peterman, A. Potts, M. O'Donnell, K. Thompson, N. Shah, S. Oertelt-Prigione
505 [GO] 2020―Apr―05 Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Shaoqing Lei, Fang Jiang, Wating Su, Chang Chen, Jingli Chen, Wei Mei, et al. (+6)
506 [GO] 2020―Apr―03 Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures Huai-liang Wu, Jian Huang, Casper J.P. Zhang, Zonglin He, Wai-Kit Ming
507 [GO] 2020―Mar―28 A systems approach to preventing and responding to COVID-19 Declan Terence Bradley, Mariam Abdulmonem Mansouri, Frank Kee, Leandro Martin Totaro Garcia
508 [GO] 2020―Mar―27 The Italian war-like measures to fight coronavirus spreading: Re-open closed hospitals now Alessandro Miani, Ernesto Burgio, Prisco Piscitelli, Renato Lauro, Annamaria Colao
509 [GO] 2020―Mar―03 The coronavirus 2019-nCoV epidemic: Is hindsight 20/20? Monica Malta, Anne W. Rimoin, Steffanie A. Strathdee
 [1] 

509 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.156 sec